{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "6cad173a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "d4f2f45a",
   "metadata": {},
   "outputs": [],
   "source": [
    "who_url = 'https://ghoapi.azureedge.net/api/Indicator/'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "66005dae",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 Ambient air pollution  attributable DALYs per 100'000 children under 5 years\n",
      "1 Household air pollution attributable deaths\n",
      "2 Household air pollution attributable deaths in children under 5 years\n",
      "3 Household air pollution attributable deaths per 100'000 capita\n",
      "4 Household air pollution  attributable deaths per 100'000 children under 5 years\n",
      "5 Household air pollution attributable DALYs\n",
      "6 Household air pollution attributable DALYs in children under 5 years\n",
      "7 Household air pollution attributable DALYs (per 100 000 population)\n",
      "8 Household air pollution  attributable DALYs per 100'000 children under 5 years\n",
      "9 Household air pollution attributable DALYs (per 100 000, age-standardized)\n",
      "10 Ambient air pollution attributable deaths in children under 5 years\n",
      "11 Ambient air pollution attributable deaths\n",
      "12 Ambient air pollution attributable death rate (per 100 000 population, age-standardized)\n",
      "13 Ambient air pollution attributable DALYs\n",
      "14 DALYs attributable to ambient air pollution (age-standardized)\n",
      "15 Ambient air pollution attributable YLLs\n",
      "16 Ambient air pollution attributable death rate (per 100 000 population)\n",
      "17 Ambient air pollution attributable deaths (per 100 000 population, age-standardized)\n",
      "18 Household air pollution attributable death rate (per 100 000 population)\n",
      "19 Household air pollution attributable death rate (per 100 000 population, age-standardized)\n",
      "20 Ambient air pollution  attributable deaths per 100'000 children under 5 years\n",
      "21 Ambient air pollution attributable DALYs\n",
      "22 Ambient air pollution attributable DALYs  in children under 5 years\n",
      "23 Ambient air pollution attributable DALYs  (per 100 000 population)\n",
      "24 Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)\n",
      "25 Functioning national AMR surveillance plan\n",
      "26 Establishment of National Coordination Centre (NCC)\n",
      "27 Nomination of National Focal Point (NFP)\n",
      "28 Establishment of national reference laboratory (NRL)\n",
      "29 EQA provided to the national reference laboratory (NRL)\n",
      "30 EQA provided for bacterial identification and AST\n",
      "31 EQA provided to local laboratories participating in GLASS\n",
      "32 GLASS pathogens testing covered by EQA\n",
      "33 Types of AST standards followed by countries\n",
      "34 Number of national surveillance sites in each country providing data to GLASS: hospital category\n",
      "35 Number of National surveillance sites in each country providing data to GLASS: outpatient facility category\n",
      "36 Number of local clinical laboratories in each country performing AST to support national AMR surveillance sites\n",
      "37 Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (%\n",
      "38 Antenatal care coverage - at least one visit (in the five years preceding the survey) (%)\n",
      "39 Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%)\n",
      "40 Antenatal care coverage - at least four visits (in the five years preceding the survey) (%)\n",
      "41 Adolescent fertility rate (per 1000 women aged 15-19 years)\n",
      "42 Prevalence of met need of assistive products (%)\n",
      "43 Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)\n",
      "44 Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)\n",
      "45 Mean systolic blood pressure (crude estimate)\n",
      "46 Mean systolic blood pressure (age-standardized estimate)\n",
      "47 Process evaluation was employed to assess implementation\n",
      "48 Formative research was conducted\n",
      "49 Outcome evaluation was employed to assess effectiveness\n",
      "50 Campaign was part of a comprehensive tobacco control programme\n",
      "51 Campaign was pre-tested\n",
      "52 Campaign utilized media planning\n",
      "53 At least one national mass media campaign ran during the survey period\n",
      "54 Earned media/public relations were used to promote the campaign\n",
      "55 Campaign aired on television and/or radio\n",
      "56 Children aged < 5 years with pneumonia symptoms taken to a health facility (%)\n",
      "57 Congenital syphilis number of reported cases\n",
      "58 Cataract surgical coverage of adults aged 50 and over (%)\n",
      "59 Effective cataract surgical coverage of adults aged 50 and over (%)\n",
      "60 Climate change attributable deaths\n",
      "61 Climate change attributable DALYs ('000)\n",
      "62 Climate change attributable deaths per 100'000 capita\n",
      "63 Climate change attributable DALYs per 100'000 capita\n",
      "64 Climate change attributable deaths ('000) in children under 5 years\n",
      "65 Climate change  attributable deaths per 100'000 children under 5 years\n",
      "66 Climate change attributable DALYs ('000) in children under 5 years\n",
      "67 Climate change  attributable DALYs per 100'000 children under 5 years\n",
      "68 Composite coverage index (%)\n",
      "69 Composite coverage index (%)\n",
      "70 Poverty headcount ratio at $1.25 a day (PPP) (% of population)\n",
      "71 Human development index rank\n",
      "72 Gender inequality index rank\n",
      "73 Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)\n",
      "74 Number of reported cases of cholera\n",
      "75 Number of reported deaths from cholera\n",
      "76 Cholera case fatality rate\n",
      "77 Number of under-five deaths\n",
      "78 Number of infant deaths\n",
      "79 Number of neonatal deaths\n",
      "80 Contraceptive prevalence - modern and traditional methods (%)\n",
      "81 Births by caesarean section (in the two or three years preceding the survey) (%)\n",
      "82 Births by caesarean section (in the five years preceding the survey) (%)\n",
      "83 Total density per 100 000 population: Hospitals\n",
      "84 Total density per 100 000 population: Health posts\n",
      "85 Total density per 100 000 population: Health centres\n",
      "86 Total density per 100 000 population: District/rural hospitals\n",
      "87 Total density per 100 000 population: Provincial hospitals\n",
      "88 Total density per 100 000 population: Specialized hospitals\n",
      "89 Availability of national standards or recommended lists of medical devices\n",
      "90 Types of lists recommending health technology for high burden diseases\n",
      "91 Total density per million population: Magnetic Resonance Imaging\n",
      "92 Total density per million population: Computed tomography units\n",
      "93 Total density per million population: Positron Emission tomography\n",
      "94 Total density per million population: Gamma camera or Nuclear medicine\n",
      "95 Total density per million population: Linear Accelerator\n",
      "96 Type of nomenclature system\n",
      "97 Use of nomenclature system\n",
      "98 Health technology (medical device) national policy\n",
      "99 Unit in the Ministry of Health responsible for the management of medical devices\n",
      "100 Procurement of medical devices carried out at the national level\n",
      "101 Availability of national list of approved medical devices for procurement or reimbursement\n",
      "102 National guidelines, policies or recommendations on the procurement of medical devices\n",
      "103 Availability of technical specifications of medical devices to support procurement or donations\n",
      "104 Total density per million population: Telecobalt Unit\n",
      "105 Total density per million population: Radiotherapy units\n",
      "106 Total density per million females aged from 50 to 69 years old: Mammography units\n",
      "107 Enforcing bans on tobacco advertising, promotion and sponsorship\n",
      "108 Compliance of ban on advertising on national TV and radio\n",
      "109 Ban on advertising: National TV and radio\n",
      "110 Compliance of ban on promotional discounts\n",
      "111 Ban on promotional discounts\n",
      "112 Ban on non-tobacco goods AND services identified with tobacco brand names\n",
      "113 Compliance of ban on non-tobacco goods AND services identified with tobacco brand names\n",
      "114 Ban on brand name of non-tobacco products used for tobacco product\n",
      "115 Compliance of ban on brand name of non-tobacco products used for tobacco product\n",
      "116 Ban on appearance of tobacco brands in TV and/or films (product placement)\n",
      "117 Compliance of ban on appearance of tobacco brands in TV and/or films (product placement)\n",
      "118 Compliance of ban on appearance of tobacco products in TV and/or films\n",
      "119 Appearance of tobacco products in TV and/or films\n",
      "120 Ban on appearance of tobacco products in TV and/or films\n",
      "121 Requirement to present prescribed anti-tobacco ads before, during or after the broadcasting or showing of any visual entertainment media product that depicts tobacco products, use or images\n",
      "122 Compliance of ban on sponsored events\n",
      "123 Sponsored events\n",
      "124 Complete ban on sponsorship\n",
      "125 Ban on any form of contribution (financial or other support) to any event, activity or individual\n",
      "126 Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals\n",
      "127 Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities\n",
      "128 Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility activities of the tobacco companies\n",
      "129 Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth\n",
      "130 Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images\n",
      "131 Ban on advertising: International TV and radio (broadcast from abroad, including satellite)\n",
      "132 Complete ban on tobacco vending machines\n",
      "133 Subnational bans on tobacco advertising, promotion and sponsorship\n",
      "134 Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place\n",
      "135 Ban on internet sales of tobacco products\n",
      "136 Ban on display of tobacco products at points of sale\n",
      "137 Law requires fines for violations of direct advertising bans\n",
      "138 Law requires fines for violations of indirect advertising bans\n",
      "139 Compliance of ban on advertising on local magazines and newspapers\n",
      "140 Ban on advertising: Local magazines and newspapers\n",
      "141 Ban on advertising: International magazines and newspapers\n",
      "142 Ban on advertising: Billboards and outdoor advertising\n",
      "143 Compliance of ban on advertising on billboards and outdoor advertising\n",
      "144 Compliance of ban on advertising at point of sale\n",
      "145 Ban on advertising: Point of sale\n",
      "146 Ban on display of tobacco products at points of sale\n",
      "147 Ban on advertising: Internet\n",
      "148 Compliance of ban on free distribution of tobacco products in the mail or through other means\n",
      "149 Ban on free distribution of tobacco products in the mail or through other means\n",
      "150 Compliance with bans on direct advertising\n",
      "151 Compliance with bans on promotion and sponsorship\n",
      "152 Electric field (kV/m)\n",
      "153 Electric field (kV/m)\n",
      "154 Electric field (V/m)\n",
      "155 Magnetic flux density (microT)\n",
      "156 Power density (W/m^2)\n",
      "157 Power frequency (Hz)\n",
      "158 Specific absorption rate (SAR) (W/kg)\n",
      "159 Existence of standards\n",
      "160 Legislative status\n",
      "161 Availability of estimates on large  health expenditures as a share of total expenditure or income\n",
      "162 Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (millions)\n",
      "163 Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (%)\n",
      "164 Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, reported data) (%)\n",
      "165 Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (millions)\n",
      "166 Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (%)\n",
      "167 Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, reported data) (%)\n",
      "168 Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (millions)\n",
      "169 Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (%)\n",
      "170 Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (millions)\n",
      "171 Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (%)\n",
      "172 Population  pushed below the $1.90 a day  poverty line by household  health expenditures (%)\n",
      "173 Population  pushed below the $3.10 a day  poverty line by household  health expenditures (%)\n",
      "174 Increase in poverty gap due to household  health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%)\n",
      "175 Increase in poverty gap due to household  health expenditures, expressed as a proportion of the 3.10 a-day poverty line (%)\n",
      "176 Availability of estimates on impoverishment due to out-of-pocket health expenditures\n",
      "177 Demand for family planning satisfied - modern and traditional methods (%)\n",
      "178 Demand for family planning satisfied - modern methods (%)\n",
      "179 Age-standardized DALYs (per 100,000)\n",
      "180 National regulator approval of anti-dementia medication\n",
      "181 Availability of generic anti-dementia medication\n",
      "182 Availability of at least one anti-dementia medication approved for on-label use reimbursement\n",
      "183 Availability of atleast one adult hygiene products for people with dementia\n",
      "184 Availability of atleast one housing adjustment for people with dementia\n",
      "185 Availability of  atleast one assistive technology for people with dementia\n",
      "186 Existence of dementia national nongovernmental organization\n",
      "187 Dementia nongovernmental organization equipped with office\n",
      "188 Dementia nongovernmental organization office branches (Sub-national)\n",
      "189 Dementia nongovernmental organization office branches (Local)\n",
      "190 Dementia nongovernmental organization office branches (National only)\n",
      "191 Dementia nongovernmental organization staff primarily salaried/volunteer\n",
      "192 Provision of governmental funding to dementia nongovernmental organization for activities/services\n",
      "193 Dementia nongovernmental organization's involvement in policy development\n",
      "194 Existence of dementia carer support services\n",
      "195 Implementation level [national/subnational] of dementia carer support services\n",
      "196 Existence of dedicated resources for dementia carer support services\n",
      "197 Existence of implementation plan for dementia carer support services\n",
      "198 Existence of psycho-social supports for dementia carers\n",
      "199 Existence of respite care for dementia carers\n",
      "200 Existence of information on legal rights for dementia carers\n",
      "201 Existence of financial benefits/social protection for dementia carers\n",
      "202 Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "203 Majority provider of dementia carer training and education (NGO)\n",
      "204 Majority provider of dementia carer training and education (Private sector)\n",
      "205 Majority provider of dementia carer training and education (Public sector)\n",
      "206 Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "207 Majority provider of psycho-social supports for dementia carers (NGO)\n",
      "208 Majority provider of psycho-social supports for dementia carers (Private sector)\n",
      "209 Majority provider of psycho-social supports for dementia carers (Public sector)\n",
      "210 Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "211 Majority provider of respite care for dementia carers (NGO)\n",
      "212 Majority provider of respite care for dementia carers (Private sector)\n",
      "213 Majority provider of respite care for dementia carers (Public sector)\n",
      "214 Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "215 Majority provider of information on legal rights for dementia carers (NGO)\n",
      "216 Majority provider of information on legal rights for dementia carers (Private sector)\n",
      "217 Majority provider of information  on legal rights for dementia carers (Public sector)\n",
      "218 Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "219 Majority provider of information on financial benefits/social protection for dementia carers (NGO)\n",
      "220 Majority provider of information on financial benefits/social protection for dementia carers (Private sector)\n",
      "221 Majority provider of information  on financial benefits/social protection for dementia carers (Public sector)\n",
      "222 Estimated number of dementia carers receiving training and education\n",
      "223 Estimated number of dementia carers receiving psycho-social supports\n",
      "224 Estimated number of dementia carers receiving respite care\n",
      "225 Estimated number of dementia carers receiving information on legal rights\n",
      "226 Estimated number of dementia carers receiving financial benefits/social protection\n",
      "227 Existence of at least one functioning dementia awareness campaign\n",
      "228 Implementation level [national/subnational] of dementia awareness campaign\n",
      "229 Existence of at least one functioning risk reduction campaign\n",
      "230 Implementation level [national/subnational] of dementia risk reduction campaign\n",
      "231 Availability of dementia-friendly initiatives that improve accessibility\n",
      "232 Existence of dementia-friendly initiative to improve accessibility of public spaces\n",
      "233 Existence of dementia-friendly initiative to improve accessibility of public transportation\n",
      "234 Existence of dementia-friendly initiative for assistance with home modification\n",
      "235 Existence of dementia-friendly initiative with assistive technology for loss of capacity\n",
      "236 Existence of dementia-friendly initiative supporting community places for older people\n",
      "237 Existence of dementia-friendly initiative supporting social opportunities\n",
      "238 Inclusion of dementia training and education for non-health workers\n",
      "239 Existence of dementia training for volunteers\n",
      "240 Existence of dementia training for police and fire services\n",
      "241 Existence of dementia training for first responders\n",
      "242 Existence of dementia training for legal professionals\n",
      "243 Existence of dementia training for community workers\n",
      "244 Existence of dementia training for school children\n",
      "245 Existence of dementia training for financial service staff\n",
      "246 Existence of dementia training for retail and hospitality staff\n",
      "247 Routine monitoring of people with dementia\n",
      "248 Data sources used to routinely monitor people with dementia (Clinical records)\n",
      "249 Data sources used to routinely monitor people with dementia (Household surveys)\n",
      "250 Data sources used to routinely monitor people with dementia (Administrative data)\n",
      "251 Data sources used to routinely monitor people with dementia (Facility survey or records)\n",
      "252 Data sources used to routinely monitor people with dementia (Other)\n",
      "253 Electronic availability of data sources used to routinely monitor people with dementia\n",
      "254 Data used to routinely monitor people with dementia can be disaggregated\n",
      "255 Availability of routine hospital admissions records for people with dementia for monitoring purposes\n",
      "256 Availability of routine outpatient visit records for people with dementia for monitoring purposes\n",
      "257 Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes\n",
      "258 Availability of routine pharmaceutical records for people with dementia for monitoring purposes\n",
      "259 Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes\n",
      "260 Availability and status of dementia reporting in the past two years\n",
      "261 Existence of a current dementia research plan/programme\n",
      "262 Implementation level [national/subnational] of dementia research plan/programme\n",
      "263 Dementia integrated into other national research plan/programme\n",
      "264 Identification of other research plans in which dementia is integrated (Mental health)\n",
      "265 Identification of other research plans in which dementia is integrated (Ageing)\n",
      "266 Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease)\n",
      "267 Identification of other research plans in which dementia is integrated (NCD)\n",
      "268 Implementation level [national/subnational] of research plan in which dementia is integrated\n",
      "269 Availability of funding for dementia-specific research plan/programme\n",
      "270 Total expenditure on dementia research (local currency, self-report)\n",
      "271 Total expenditure on dementia basic research (local currency, self-report)\n",
      "272 Total expenditure on dementia clinical/translational research (local currency, self-report)\n",
      "273 Total expenditure on dementia implementation research (local currency, self-report)\n",
      "274 Number of people with dementia involved in research routinely monitored\n",
      "275 Availability of investigational pharmaceutical trials for dementia\n",
      "276 Number of investigational pharmaceutical trials for dementia\n",
      "277 Inclusion of dementia in ministry portfolio\n",
      "278 Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease]\n",
      "279 Existence of dementia representative in ministry\n",
      "280 Total number of published dementia research output\n",
      "281 Existence of dementia national plan\n",
      "282 Availability of funding for dementia national plan\n",
      "283 Targets for monitoring implementation of dementia national plan\n",
      "284 Dementia integrated into other national plan\n",
      "285 Identification of other plans in which dementia is integrated (Ageing)\n",
      "286 Identification of other plans in which dementia is integrated (Disability)\n",
      "287 Identification of other plans in which dementia is integrated (Mental health)\n",
      "288 Identification of other plans in which dementia is integrated (NCD)\n",
      "289 Identification of other plans in which dementia is integrated (Other)\n",
      "290 Existence of dementia sub-national plan(s)\n",
      "291 Percentage of sub-national regions covered by dementia plan\n",
      "292 Inclusion of human rights as a guiding principle of the dementia plan\n",
      "293 Inclusion of equity as a guiding principle of the dementia plan\n",
      "294 Inclusion of empowerment as a guiding principle of the dementia plan\n",
      "295 Inclusion of multisectoral collaboration as a guiding principles of the dementia plan\n",
      "296 Inclusion of universal health coverage as a guiding principle of the dementia plan\n",
      "297 Inclusion of dementia-friendly communities as a specific action of the dementia plan\n",
      "298 Inclusion of dementia risk reduction as a specific action of the dementia plan\n",
      "299 Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan\n",
      "300 Inclusion of dementia workforce training as a specific action of the dementia plan\n",
      "301 Inclusion of support for dementia carers and families as a specific action of the dementia plan\n",
      "302 Inclusion of improved information system as a specific action of the dementia plan\n",
      "303 Inclusion of research and innovation as a specific action of the dementia plan\n",
      "304 Estimated population-based prevalence of depression\n",
      "305 Existence of dementia legislation\n",
      "306 Implementation level [national/subnational] of dementia legislation\n",
      "307 Existence of other laws that apply to the rights of people with dementia\n",
      "308 Existence of legislation for supported decision making for people with dementia\n",
      "309 Existence of legislation to file appeals protecting the rights of people with dementia\n",
      "310 Existence of legislation to promote community-based services for people with dementia\n",
      "311 Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside\n",
      "312 Existence of legislation to end coercieve practices for people with dementia\n",
      "313 Existence of legislation for advanced care directives for people with dementia\n",
      "314 Existence of legislation to end discrimination against people with dementia\n",
      "315 Existence of legislation to end discrimination against carers of people with dementia\n",
      "316 Existence of dementia standards/ guidelines/ protocols\n",
      "317 Implementation level of dementia standards/ guidelines/ protocols (National)\n",
      "318 Implementation level of dementia standards/ guidelines/ protocols (Sub-national)\n",
      "319 Existence of approved government dementia standards/ guidelines/ protocols\n",
      "320 Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia\n",
      "321 Existence of standards/ guidelines/ protocols for diagnosis of dementia\n",
      "322 Existence of standards/ guidelines/ protocols for management of dementia\n",
      "323 Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia\n",
      "324 Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia\n",
      "325 Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia\n",
      "326 Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia\n",
      "327 Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia\n",
      "328 Existence of standards/ guidelines/ protocols of care in hospital for people with dementia\n",
      "329 Availability of mechanisms to coordinate dementia care across sectors\n",
      "330 Identification of different sectors in dementia care coordination  (Health)\n",
      "331 Identification of different sectors in dementia care coordination (Social)\n",
      "332 Identification of different sectors in dementia care coordination (Education)\n",
      "333 Identification of different sectors in dementia care coordination (Employment)\n",
      "334 Identification of different sectors in dementia care coordination (Justice)\n",
      "335 Identification of different sectors in dementia care coordination (Housing)\n",
      "336 Identification of different sectors in dementia care coordination (Civil society)\n",
      "337 Identification of different sectors in dementia care coordination (Private sector)\n",
      "338 Identification of different sectors in dementia care coordination (Other)\n",
      "339 Implementation level [national/subnational] of dementia care coordination\n",
      "340 Presence of formal agreement/joint plan for dementia care coordination\n",
      "341 Availability of dementia care coordination standards/ guidelines/ protocols\n",
      "342 Number of neurologists (per 100,000)\n",
      "343 Number of geriatricians or psychogeriatricians (per 100,000)\n",
      "344 Inclusion of basic dementia competencies in training of physicians\n",
      "345 Inclusion of basic dementia competencies in training of specialists\n",
      "346 Inclusion of basic dementia competencies in training of nurses\n",
      "347 Inclusion of basic dementia competencies in training of pharmaceutical personnel\n",
      "348 Inclusion of basic dementia competencies in training of social workers\n",
      "349 Inclusion of basic dementia competencies in training of personal support workers\n",
      "350 Availability of dementia diagnostic rate\n",
      "351 Existence of community-based health or social care services for dementia\n",
      "352 Availability of diagnostic services in community for dementia\n",
      "353 Availability of behaviour and psychological management in community for dementia\n",
      "354 Availability of psychosocial and rehabilitation services in community for dementia\n",
      "355 Availability of activities of daily living support services in community for dementia\n",
      "356 Availability of palliative and end-of-life care services in community for dementia\n",
      "357 Availability of social and financial protection for dementia\n",
      "358 Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "359 Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "360 Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "361 Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "362 Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "363 Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas]\n",
      "364 Majority provider of diagnostic services in community for dementia [public, private]\n",
      "365 Majority provider of behaviour and psychological management in community for dementia [public, private]\n",
      "366 Majority provider of psychosocial and rehabilitation services in community for dementia [public, private]\n",
      "367 Majority provider of activities of daily living support services in community for dementia [public, private]\n",
      "368 Majority provider of palliative and end-of-life care services in community for dementia [public, private]\n",
      "369 Majority provider of social and financial protection for dementia [public, private]\n",
      "370 Estimated number of people receiving behaviour and psychological management services in community for dementia\n",
      "371 Estimated number of people receiving psychosocial and rehabilitation services in community for dementia\n",
      "372 Estimated number of people receiving activities of daily living support services in community for dementia\n",
      "373 Estimated number of people receiving palliative and end-of-life care services in community for dementia\n",
      "374 Estimated number of people with dementia receiving social and financial protection for dementia\n",
      "375 Dementia care facilities [hospitals]\n",
      "376 Care facilities [long-term care]\n",
      "377 Care facilities [hospice centres]\n",
      "378 Adult day centres\n",
      "379 Outpatient health centres\n",
      "380 Outpatient social centres\n",
      "381 Dementia-specific hospital beds (per 10,000 population)\n",
      "382 Geriatric-specific hospital beds (per 10,000 population)\n",
      "383 Total dementia hospital admissions (per 100,000)\n",
      "384 Estimated percentage of hospitals following national dementia standards\n",
      "385 Density of residential long-term care facilities (per 100,000 population)\n",
      "386 Residential long-term care beds (per 10 000 population)\n",
      "387 Dementia-specific residential long-term care beds (per 10,000 population)\n",
      "388 Estimated number of people with dementia living in residential long-term care\n",
      "389 Estimated percentage of residential long-term care facilities following national dementia standards\n",
      "390 Density of hospice centres (per 100,000 population)\n",
      "391 Hospice centre beds (per 10 000 population)\n",
      "392 Dementia-specific hospice care beds (per 10,000 population)\n",
      "393 Density of adult day centres (per 100,000 population)\n",
      "394 Adult day centre places (per 10,000 population)\n",
      "395 Dementia-specific adult day centre places (per 10,000 population)\n",
      "396 Density of outpatient health centres (per 100,000 population)\n",
      "397 Estimated number of people with dementia receiving services at outpatient health centre\n",
      "398 Density of outpatient social centres (per 100,000 population)\n",
      "399 Estimated number of people with dementia receiving services at outpatient social centre\n",
      "400 Disability-adjusted life years (DALYs)\n",
      "401 Disability-adjusted life years (DALYs) (per 100 000 population)\n",
      "402 Years of healthy life lost due to disability (YLDs)\n",
      "403 Years of healthy life lost due to disability (YLDs) (per 100 000 population)\n",
      "404 Years of life lost from mortality (YLLs)\n",
      "405 Years of life lost from mortality (YLLs) (per 100 000 population)\n",
      "406 Current health expenditure (CHE) per capita in PPP int$\n",
      "407 Current health expenditure (CHE) per capita in US$\n",
      "408 Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)\n",
      "409 External health expenditure (EXT) per capita in PPP int$\n",
      "410 External health expenditure (EXT) per capita in US$\n",
      "411 External health expenditure (EXT) as percentage of current health expenditure (CHE) (%)\n",
      "412 Domestic general government health expenditure (GGHE-D) per capita in PPP int$\n",
      "413 Domestic general government health expenditure (GGHE-D) per capita in US$\n",
      "414 Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%)\n",
      "415 Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%)\n",
      "416 Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%)\n",
      "417 Out-of-pocket expenditure (OOP) per capita in PPP int$\n",
      "418 Out-of-pocket expenditure (OOP) per capita in US$\n",
      "419 Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%)\n",
      "420 Domestic private health expenditure (PVT-D) per capita in PPP int$\n",
      "421 Domestic private health expenditure (PVT-D) per capita in US$\n",
      "422 Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)\n",
      "423 National universal health coverage strategy\n",
      "424 strategy refers to the use of ICT to support UHC\n",
      "425 National eHealth strategy\n",
      "426 National eHealth strategy refers to objectives of UHC\n",
      "427 National  health information system (HIS) policy or strategy\n",
      "428 Public funding for eHealth\n",
      "429 Private funding for eHealth\n",
      "430 Donor/ non-public development funding for eHealth\n",
      "431 Public-private partnerships for eHealth\n",
      "432 Strategy implementation funding available for eHealth\n",
      "433 Proportion of public funding\n",
      "434 Proportion of private funding\n",
      "435 Proportion of donor/non public development funding\n",
      "436 Proportion ofpublic private partnerships funding\n",
      "437 Government-supported health internet sites provide information in multiple languages\n",
      "438 Tertiary institutions provide students of health sciences with training on eHealth\n",
      "439 Institutions offer in-service training to health professionals on ICT for health\n",
      "440 mHealth programmes are sponsored by government\n",
      "441 Regulating mobile devices and software\n",
      "442 Promoting standards and interoperability\n",
      "443 Providing guidance on privacy and security\n",
      "444 Providing oversight and enforcement of data ownership\n",
      "445 Promoting the development and adoption of mHealth\n",
      "446 Regulatory oversight of mobile apps for quality, safety and reliability\n",
      "447 Providing incentives and guidance for innovation research and evaluation of health\n",
      "448 Government-sponsored mHealth programmes are being evaluated\n",
      "449 Capacity\n",
      "450 Infrastructure\n",
      "451 Funding\n",
      "452 Effectiveness\n",
      "453 Cost-effectiveness\n",
      "454 Demand\n",
      "455 Legal\n",
      "456 Policy\n",
      "457 Priorities\n",
      "458 Country has telehealth policy or strategy\n",
      "459 Strategy includes objectives as to how telehealth contributes to UHC\n",
      "460 Evaluation of any government-sponsored telehealth programmes\n",
      "461 eLearning is used in pre-service education to teach health sciences students\n",
      "462 Reducing cost of delivering content\n",
      "463 Improving access to content and experts\n",
      "464 Enabling access to education where learning facilities are limited\n",
      "465 Pre-service eLearning programmes have been evaluated\n",
      "466 eLearning used for in-service training of health professionals\n",
      "467 Reducing cost of delivering content\n",
      "468 Improving access to content and experts\n",
      "469 Enabling access to education where learning facilities are limited\n",
      "470 eLearning courses accredited by continuing medical education or professional licensing bodies\n",
      "471 eLearning programmes for in-service training of health professionals have been evaluated\n",
      "472 Lack of capacity\n",
      "473 Lack of infrastructure\n",
      "474 Lack of funding\n",
      "475 Not possible to gain a health sciences degree entirely through eLearning\n",
      "476 Lack of evidence that eLearning is effective\n",
      "477 Lack of evidence over cost-effectiveness\n",
      "478 Lack of demand for eLearning programmes\n",
      "479 Lack of suitable courses available\n",
      "480 Insitutional educational policy does not include eLearning as an approach to teaching health sciences\n",
      "481 Competing educational priorities\n",
      "482 Country has national EHR\n",
      "483 Country has specific legislation governing the use of national EHR system\n",
      "484 Lack of capacity\n",
      "485 Lack of infrastructure\n",
      "486 Lack of funding\n",
      "487 lack of evidence showing effectiveness of EHR\n",
      "488 Lack of evidence showing cost-effectiveness or EHR\n",
      "489 Lack of demand by health professionals and patients\n",
      "490 Lack of legislation or regulations covering use of EHR\n",
      "491 National strategy does not promote the adoption of EHR\n",
      "492 Lack of national or international standards for interoperability of EHR\n",
      "493 Competing health system priorities\n",
      "494 To define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth\n",
      "495 To address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria\n",
      "496 To protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format\n",
      "497 To protect the privacy of individuals' health-related  data held in electronic format as an EHR\n",
      "498 Which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR\n",
      "499 Which governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHR\n",
      "500 Which allows for the sharing of personal and health data between research entities\n",
      "501 Which allows individuals electronic access to their own health-related data when held in an EHR\n",
      "502 Which allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccurate\n",
      "503 Which allows individuals to demand the deletion of health-related data from their EHR\n",
      "504 Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice\n",
      "505 Country has national policy or strategy on the use of social media by government organizations\n",
      "506 Policy or strategy makes specific reference tothe use of social media in the health domain\n",
      "507 Country has  national policy or strategy regulating the use of big data in the health sector\n",
      "508 Country has national policy or strategy regulating the use of big data by private companies\n",
      "509 Effective standards and best practices for data capture not fully established\n",
      "510 Insufficient incentives for data sharing\n",
      "511 Capacity building required for new skills\n",
      "512 Privacy and security laws need to be in place\n",
      "513 Research into new analytical methods needs occur to meet the challenges of working with big data\n",
      "514 Lack of integration between various health services\n",
      "515 Estimated number of people (all ages) living with HIV\n",
      "516 Number of people dying from HIV-related causes\n",
      "517 Testing and counselling facilities, reported number\n",
      "518 Testing and counselling facilities, estimated number per 100 000 adult population\n",
      "519 Reported number of people receiving antiretroviral therapy\n",
      "520 Reported number of children receiving antiretroviral therapy\n",
      "521 Reported number of children receiving antiretroviral therapy, month and year of report\n",
      "522 Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission\n",
      "523 Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission\n",
      "524 Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission\n",
      "525 Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines\n",
      "526 Estimated number of children needing antiretroviral therapy based on WHO methods\n",
      "527 Estimated antiretroviral therapy coverage among children\n",
      "528 Testing and counselling facilities, reporting period\n",
      "529 Number of new HIV infections\n",
      "530 Estimated antiretroviral therapy coverage among people living with HIV (%)\n",
      "531 Biomedical engineers density (per 10 000 population)\n",
      "532 Number of licensed qualified surgeons actively working\n",
      "533 Number of licensed qualified obstetricians actively working\n",
      "534 Number of licensed qualified anaesthesiologists actively working\n",
      "535 Number of biomedical engineers\n",
      "536 Biomedical technicians density (per 10 000 population)\n",
      "537 Number of biomedical technicians\n",
      "538 Countries that have passed legislation on Universal Health Coverage (UHC)\n",
      "539 Medical doctors (per 10,000)\n",
      "540 Medical doctors (number)\n",
      "541 Generalist medical practitioners (number)\n",
      "542 Specialist medical practitioners (number)\n",
      "543 Medical doctors not further defined (number)\n",
      "544 Nursing and midwifery personnel (per 10,000)\n",
      "545 Nursing and midwifery personnel  (number)\n",
      "546 Nursing personnel (number)\n",
      "547 Midwifery personnel (number)\n",
      "548 Dentists (per 10,000)\n",
      "549 Dentists (number)\n",
      "550 Dental Assistants and Therapists (number)\n",
      "551 Dental Prosthetic Technicians (number)\n",
      "552 Pharmacists  (per 10,000)\n",
      "553 Pharmacists  (number)\n",
      "554 Pharmaceutical Technicians and Assistants  (number)\n",
      "555 Environmental and Occupational Health and Hygiene Professionals  (number)\n",
      "556 Environmental and Occupational Health Inspectors and Associates  (number)\n",
      "557 Medical and Pathology Laboratory scientists  (number)\n",
      "558 Medical and Pathology Laboratory Technicians  (number)\n",
      "559 Physiotherapists (number)\n",
      "560 Physiotherapy Technicians and Assistants  (number)\n",
      "561 Traditional and Complementary Medicine Professionals  (number)\n",
      "562 Community Health Workers (number)\n",
      "563 Handwashing with soap after using the toilet (%)\n",
      "564 Handwashing with soap after cleaning child's stool (%)\n",
      "565 Legislation\n",
      "566 Coordination\n",
      "567 Surveillance\n",
      "568 Response\n",
      "569 Preparedness\n",
      "570 Risk communication\n",
      "571 Human resources\n",
      "572 Laboratory\n",
      "573 Points of entry\n",
      "574 Zoonosis\n",
      "575 Food safety\n",
      "576 Chemical\n",
      "577 Radionuclear\n",
      "578 Infant mortality rate (deaths per 1000 live births)\n",
      "579 Percentage of sites for which carbamate resistance was reported\n",
      "580 Carbamate resistance reported for at least one site\n",
      "581 Number of insecticide classes to which resistance was reported\n",
      "582 Percentage of sites for which organochlorine resistance was reported\n",
      "583 Organochlorine resistance reported for at least one site\n",
      "584 Percentage of sites for which organophosphate resistance was reported\n",
      "585 Organophosphate resistance reported for at least one site\n",
      "586 Percentage of sites for which pyrethroid resistance was reported\n",
      "587 Pyrethroid resistance reported for at least one site\n",
      "588 Children aged < 5 years sleeping under insecticide-treated nets (%)\n",
      "589 Pregnant women sleeping under insecticide-treated nets (%)\n",
      "590 Percentage of individuals using the Internet\n",
      "591 Mobile-cellular telephone subscriptions per 100 inhabitants\n",
      "592 ICT Development Index (IDI)\n",
      "593 ICT Development Index (IDI) rank\n",
      "594 Percentage of the children under 15 years with blood lead levels above 5ug/dl\n",
      "595 Lead attributable DALYs per 100'000 children under 5 years\n",
      "596 Percentage of the children under 15 years with blood lead levels above 10ug/dl\n",
      "597 Percentage of the adults (15+ years) with blood lead levels above 5ug/dl\n",
      "598 Percentage of the adults (15+ years) with blood lead levels above 10ug/dl\n",
      "599 Lead attributable deaths\n",
      "600 Lead attributable DALYs ('000)\n",
      "601 Lead attributable deaths per 100'000 capita\n",
      "602 Lead attributable DALYs per 100'000 capita\n",
      "603 Lead attributable DALYs ('000) in children under 5 years\n",
      "604 Legally-binding controls on lead paint\n",
      "605 nMx - age-specific death rate between ages x and x+n\n",
      "606 nqx - probability of dying between ages x and x+n\n",
      "607 lx - number of people left alive at age x\n",
      "608 ndx - number of people dying between ages x and x+n\n",
      "609 nLx - person-years lived between ages x and x+n\n",
      "610 Tx - person-years lived above age x\n",
      "611 ex - expectation of life at age x\n",
      "612 Adult indicator 1 rate\n",
      "613 Youth indicator 1 rate\n",
      "614 Adult indicator 1 definition\n",
      "615 Youth indicator 1 definition\n",
      "616 Adult indicator 2 rate\n",
      "617 Youth indicator 2 rate\n",
      "618 Adult indicator 2 definition\n",
      "619 Youth indicator 2 definition\n",
      "620 Estimate of current cigarette smoking prevalence (%)\n",
      "621 Estimate of current tobacco use prevalence (%)\n",
      "622 Monitoring tobacco use and prevention policies\n",
      "623 Adult survey age range - smokeless\n",
      "624 Youth survey age range - smokeless\n",
      "625 Adult smokeless tobacco use indicator definition\n",
      "626 Youth smokeless tobacco use indicator definition\n",
      "627 Adult smokeless tobacco use indicator rate\n",
      "628 Youth smokeless tobacco use indicator rate\n",
      "629 Name of survey of adults - smokeless\n",
      "630 Name of survey of youth - smokeless\n",
      "631 Representativeness of survey of adults - smokeless\n",
      "632 Representativeness of survey of youth - smokeless\n",
      "633 Name of survey of adults\n",
      "634 Name of survey of youth\n",
      "635 Adult survey age range\n",
      "636 Youth survey age range\n",
      "637 Representativeness of survey of adults\n",
      "638 Representativeness of youth survey\n",
      "639 Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)\n",
      "640 Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)\n",
      "641 Adolescent birth rate (per 1000 women aged 15-19 years)\n",
      "642 Under-five mortality rate (probability of dying by age 5 per 1000 live births)\n",
      "643 Median availability of selected generic medicines (%) - Public\n",
      "644 Median consumer price ratio of selected generic medicines - Public\n",
      "645 Children aged <5 years with fever who received treatment with any antimalarial (%)\n",
      "646 Prevalence of condom use by adults during higher-risk sex (15-49) (%)\n",
      "647 Deaths due to tuberculosis among HIV-negative people (per 100 000 population)\n",
      "648 Incidence of tuberculosis (per 100 000 population per year)\n",
      "649 Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%)\n",
      "650 Births attended by skilled health personnel (%)\n",
      "651 Births attended by skilled health personnel, among girls aged 15-19 (%)\n",
      "652 Maternal mortality ratio (per 100 000 live births)\n",
      "653 Prevalence of HIV among adults aged 15 to 49 (%)\n",
      "654 Smear-positive tuberculosis case-detection rate (%)\n",
      "655 Smear-positive tuberculosis treatment-success rate (%)\n",
      "656 Maternal mortality ratio (per 100 000 live births) - Country reported estimates\n",
      "657 Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)\n",
      "658 Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines\n",
      "659 Number of suspected meningitis deaths reported\n",
      "660 Number of suspected meningitis cases reported\n",
      "661 Number of meningitis epidemic districts\n",
      "662 Mental health policy\n",
      "663 Mental health outpatient facilities (per 100,000)\n",
      "664 Mental health day treatment facilities (per 100,000)\n",
      "665 Age-standardized suicide rates (per 100 000 population)\n",
      "666 Beds for mental health in general hospitals (per 100,000)\n",
      "667 Community residential facilities (per 100,000)\n",
      "668 Beds in community residential facilities (per 100,000)\n",
      "669 Beds in mental hospitals (per 100,000)\n",
      "670 Mental hospitals (per 100,000)\n",
      "671 Mental health units in general hospitals (per 100,000)\n",
      "672 Mental hospital admissions (per 100,000)\n",
      "673 Mental health plan\n",
      "674 Outpatient visits (per 100,000)\n",
      "675 Mental health units in general hospitals admissions (per 100,000)\n",
      "676 Stand-alone policy or plan for mental health\n",
      "677 Stand-alone mental health legislation\n",
      "678 Government expenditures on mental health as a percentage of total government expenditures on health (%)\n",
      "679 Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)\n",
      "680 Psychiatrists working in mental health sector (per 100,000)\n",
      "681 Nurses working in mental health sector (per 100,000)\n",
      "682 Social workers working in mental health sector (per 100,000)\n",
      "683 Psychologists working in mental health sector (per 100,000)\n",
      "684 Number of deaths\n",
      "685 Deaths per 1 000 live births\n",
      "686 Distribution of causes of death among children aged < 5 years (%)\n",
      "687 Deaths per 100 000 population\n",
      "688 Number of deaths\n",
      "689 Projection of number of deaths\n",
      "690 Projection of deaths per 100 000 population\n",
      "691 Number of maternal deaths\n",
      "692 Adolescent mortality rate (per 100 000 population)\n",
      "693 Prevalence of underweight among adults, BMI < 18 (age-standardized estimate) (%)\n",
      "694 Prevalence of underweight among adults, BMI < 18 (crude estimate) (%)\n",
      "695 Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)\n",
      "696 Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)\n",
      "697 Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)\n",
      "698 Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)\n",
      "699 Mean BMI (kg/m²) (age-standardized estimate)\n",
      "700 Mean BMI (kg/m&#xb2;) (crude estimate)\n",
      "701 Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)\n",
      "702 Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)\n",
      "703 Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)\n",
      "704 General availability of ACE inhibitors in the public health sector\n",
      "705 Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol\n",
      "706 General availability of aspirin (100 mg) in the public health sector\n",
      "707 General availability of beta blockers in the public health sector\n",
      "708 General availability of colon cancer screening at the primary health care level\n",
      "709 General availability of breast cancer screening (by palpation or mammogram) at the primary health care level\n",
      "710 Existence of national screening program for breast cancer\n",
      "711 General availability of bronchodilators in the public health sector\n",
      "712 Existence of operational policy/strategy/action plan for cancer\n",
      "713 Existence of population-based cancer registry\n",
      "714 General availability of CC blockers in the public health sector\n",
      "715 General availability of cervical cytology at the primary health care level\n",
      "716 Most widely used screening method in national cervical cancer screening program\n",
      "717 Coverage of national cervical cancer screening program (%)\n",
      "718 Type of national cervical cancer screening program\n",
      "719 Existence of national screening program for cervical cancer\n",
      "720 General availability of chemotherapy in the public health system\n",
      "721 General availability of total cholesterol measurement at the primary health care level\n",
      "722 General availability of coronary bypass or stenting in the public health system\n",
      "723 Existence of operational policy/strategy/action plan for chronic respiratory diseases\n",
      "724 Existence of operational policy/strategy/action plan for cardiovascular diseases\n",
      "725 Existence of a diabetes registry\n",
      "726 General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level\n",
      "727 Existence of operational policy/strategy/action plan for diabetes\n",
      "728 General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level\n",
      "729 General availability of dialysis in the public health system\n",
      "730 Implementation of diet and/or physical activity public awareness program\n",
      "731 Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs\n",
      "732 General availability of diabetes testing (by HbA1c) at the primary health care level\n",
      "733 Existence of national HPV vaccination programme\n",
      "734 General availability of insulin in the public health sector\n",
      "735 Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors\n",
      "736 General availability of metformin in the public health sector\n",
      "737 Existence of any policies on marketing of foods to children\n",
      "738 Existence of a national multisectoral commission, agency or mechanism for NCDs\n",
      "739 Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach\n",
      "740 Existence of a set of national NCD indicators and has set time-bound national targets for these indicators\n",
      "741 Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs\n",
      "742 General availability of nicotine replacement therapy in the public health sector\n",
      "743 Existence of operational policy/strategy/action plan for oral health\n",
      "744 General availability of oral morphine in the public health sector\n",
      "745 Implementation of physical activity public awareness program\n",
      "746 General availability of palliative care in community or home-based care in the public health system\n",
      "747 General availability of palliative care in primary health care in the public health system\n",
      "748 Existence of operational policy/strategy/action plan to reduce physical inactivity\n",
      "749 General availability of peak flow measurement at the primary health care level\n",
      "750 General availability of retinal photocoagulation in the public health system\n",
      "751 Has a STEPS survey or a comprehensive health examination survey every 5 years\n",
      "752 General availability of renal replacement by transplantation in the public health system\n",
      "753 Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities\n",
      "754 Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease\n",
      "755 Existence of a register of patients who had rheumatic fever and rheumatic heart disease\n",
      "756 Availability of cardiovascular risk stratification in 50% or more primary health care facilities\n",
      "757 Existence of any policies to reduce population salt consumption\n",
      "758 Existence of national policies on saturated fatty acids / trans-fats\n",
      "759 General availability of spirometry at the primary health care level\n",
      "760 Existence of tax on sugar-sweetened beverages\n",
      "761 General availability of statins in the public health sector\n",
      "762 General availability of steroid inhalers in the public health sector\n",
      "763 Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities\n",
      "764 General availability of sulphonylurea(s) in the public health sector\n",
      "765 Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets\n",
      "766 Existence of a set of time-bound national targets based on WHO guidance\n",
      "767 General availability of thiazide diuretics in the public health sector\n",
      "768 General availability of thrombolytic therapy in the public health system\n",
      "769 Existence of operational policy/strategy/action plan to decrease tobacco use\n",
      "770 General availability of urine testing for albumin\n",
      "771 Total NCD Deaths (in thousands)\n",
      "772 Mean fasting blood glucose (mmol/l) (age-standardized estimate)\n",
      "773 Mean fasting blood glucose (mmol/l) (crude estimate)\n",
      "774 Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate)\n",
      "775 Raised fasting blood glucose (>=7.0 mmol/L) (age-standardized estimate)\n",
      "776 Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)\n",
      "777 Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)\n",
      "778 Insufficiently active (crude estimate)\n",
      "779 Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths\n",
      "780 Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease\n",
      "781 Basis for NHA estimate\n",
      "782 Neonatal mortality rate (deaths per 1000 live births)\n",
      "783 National agency for tobacco control exists\n",
      "784 Budget year\n",
      "785 Reported currency\n",
      "786 Number of full-time equivalent staff in national agency\n",
      "787 Annual budget for tobacco control in currency reported\n",
      "788 Government objectives on tobacco control exist\n",
      "789 Number of new reported cases of Buruli ulcer\n",
      "790 Dracunculiasis certification status of countries at the beginning of the year\n",
      "791 Annual incidence of dracunculiasis cases\n",
      "792 Number of new reported cases of human African trypanosomiasis (T.b. gambiense)\n",
      "793 Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense)\n",
      "794 Status of elimination of trachoma as a public health problem\n",
      "795 Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem\n",
      "796 Number of people who received treatment with antibiotics for trachoma\n",
      "797 Status of bejel endemicity\n",
      "798 Status of endemicity of cutaneous leishmaniasis\n",
      "799 Number of cases of cutaneous leishmaniasis reported\n",
      "800 Number of imported cases of cutaneous leishmaniasis reported\n",
      "801 Status of endemicity of visceral leishmaniasis\n",
      "802 Number of cases of visceral leishmaniasis reported\n",
      "803 Number of imported cases of visceral leishmaniasis reported\n",
      "804 Number of female leprosy new cases\n",
      "805 New leprosy case detection rate per 1 000 000 population\n",
      "806 Leprosy - Number of cases registered for treatment\n",
      "807 Leprosy registered prevalence rate per 1 000 000 population\n",
      "808 Number of new G2D leprosy cases\n",
      "809 Leprosy - New leprosy cases with G2D rate per 1 000 000 population\n",
      "810 Leprosy - Number of new leprosy cases among children (less than 15 years of age)\n",
      "811 Number of new leprosy cases with G2D among children (less than 15 years of age)\n",
      "812 Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis\n",
      "813 Status of endemicity of onchocerciasis\n",
      "814 Reported number of individuals treated for onchocerciasis\n",
      "815 Status of pinta endemicity\n",
      "816 Reported number of human rabies deaths\n",
      "817 Number of people operated for trachomatous trichiasis\n",
      "818 Status of endemicity of Taenia solium\n",
      "819 Number of pigs in the country\n",
      "820 Practice of backyard pig production\n",
      "821 Status of yaws endemicity\n",
      "822 Number of cases of yaws reported\n",
      "823 Overweight numbers among children under 5 years of age (millions)\n",
      "824 Overweight prevalence among children under 5 years of age (%)\n",
      "825 Proportion of children aged 6-23 months who receive a minimum acceptable diet\n",
      "826 Children aged <5 years wasted for age (%)\n",
      "827 Early initiation of breastfeeding (%)\n",
      "828 Exclusive breastfeeding under 6 months (%)\n",
      "829 Prevalence of underweight children under 5 years of age   (% weight-for-age <-2 SD) (%)\n",
      "830 Wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD)\n",
      "831 Severe wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD)\n",
      "832 Severe wasted numbers among children under 5 years of age (millions)\n",
      "833 Severe wasted prevalence among children under 5 years of age (%)\n",
      "834 Stunting numbers among children under 5 years of age (millions)\n",
      "835 Stunting prevalence among children under 5 years of age (%)\n",
      "836 Underweight numbers among children under 5 years of age (millions)\n",
      "837 Underweight prevalence among children under 5 years of age (%)\n",
      "838 Wasted numbers among children under 5 years of age (millions)\n",
      "839 Wasted prevalence among children under 5 years of age (%)\n",
      "840 Treatment for tobacco dependence available in the community\n",
      "841 Treatment for tobacco dependence available in health clinics or other primary care facilities\n",
      "842 Treatment for tobacco dependence available in hospitals\n",
      "843 Treatment for tobacco dependence available in offices of health professionals\n",
      "844 Treatment for tobacco dependence available in other settings\n",
      "845 Bupropion - cost covered\n",
      "846 Bupropion - legally sold\n",
      "847 Bupropion - place available\n",
      "848 Offering help to quit tobacco use\n",
      "849 Treatment for tobacco dependence in the community cost covered\n",
      "850 Treatment for tobacco dependence in health clinics or other primary care facilities cost covered\n",
      "851 Treatment for tobacco dependence in hospitals cost covered\n",
      "852 Treatment for tobacco dependence in offices of health professionals cost covered\n",
      "853 Treatment for tobacco dependence in other settings cost covered\n",
      "854 Nicotine replacement therapy on the Essential Medicines List\n",
      "855 Nicotine replacement therapy - cost covered\n",
      "856 Nicotine replacement therapy - legally sold\n",
      "857 Nicotine replacement therapy - place available\n",
      "858 Access to a toll-free quit line\n",
      "859 Varenicline - cost covered\n",
      "860 Varenicline - legally sold\n",
      "861 Varenicline - place available\n",
      "862 Occupational risk factors attributable deaths\n",
      "863 Occupational carcinogens attributable DALYs ('000)\n",
      "864 Occupational carcinogens attributable deaths per 100'000 capita\n",
      "865 Occupational carcinogens attributable DALYs per 100'000 capita\n",
      "866 Occupational noise attributable DALYs ('000)\n",
      "867 Occupational noise attributable DALYs per 100'000 capita\n",
      "868 Occupational ergonomic stressors attributable deaths\n",
      "869 Occupational ergonomic stressors attributable DALYs ('000)\n",
      "870 Occupational ergonomic stressors attributable deaths per 100'000 capita\n",
      "871 Occupational ergonomic stressors attributable DALYs per 100'000 capita\n",
      "872 Occupational injuries attributable deaths\n",
      "873 Occupational risk factors attributable DALYs ('000)\n",
      "874 Occupational injuries attributable DALYs ('000)\n",
      "875 Occupational injuries attributable deaths per 100'000 capita\n",
      "876 Occupational injuries attributable DALYs per 100'000 capita\n",
      "877 Occupational risk factors attributable deaths per 100'000 capita\n",
      "878 Occupational risk factors attributable DALYs per 100'000 capita\n",
      "879 Occupational airborne particulates attributable deaths\n",
      "880 Occupational airborne particulates attributable DALYs ('000)\n",
      "881 Occupational airborne particulates attributable deaths per 100'000 capita\n",
      "882 Occupational airborne particulates attributable DALYs per 100'000 capita\n",
      "883 Occupational carcinogens attributable deaths\n",
      "884 Donor commitments (Million, constant 2009 US$)\n",
      "885 Commitments to recipient countries (Million, constant 2009 US$)\n",
      "886 Donor disbursements (Million, constant 2009 US$)\n",
      "887 Disbursements to recipient countries (Million, constant 2009 US$)\n",
      "888 Children aged < 5 years with diarrhoea receiving oral rehydration salts (%)\n",
      "889 Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%)\n",
      "890 Overweight prevalence in children aged <five years (%)\n",
      "891 National smoking ban: NUMBER OF PLACES SMOKE-FREE\n",
      "892 Protecting people from tobacco smoke\n",
      "893 Compliance of ban on smoking in HEALTH-CARE FACILITIES\n",
      "894 National smoking ban in HEALTH-CARE FACILITIES\n",
      "895 Subnational smoking bans - authority exists\n",
      "896 National smoking ban: FINES FOR VIOLATIONS\n",
      "897 National smoking ban: FINES ON THE ESTABLISHMENT\n",
      "898 National smoking ban: FINES ON THE PATRON\n",
      "899 National smoking ban: DEDICATED FUNDS FOR ENFORCEMENT\n",
      "900 National smoking ban: CITIZEN COMPLAINTS AND INVESTIGATIONS\n",
      "901 Comprehensive bans in place subnationally\n",
      "902 Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES\n",
      "903 National smoking ban in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES\n",
      "904 Compliance of ban on smoking in UNIVERSITIES\n",
      "905 National smoking ban in UNIVERSITIES\n",
      "906 Compliance of ban on smoking in GOVERNMENT FACILITIES\n",
      "907 National smoking ban in GOVERNMENT FACILITIES\n",
      "908 Compliance of ban on smoking in INDOOR OFFICES\n",
      "909 National smoking ban in INDOOR OFFICES\n",
      "910 Compliance of ban on smoking in RESTAURANTS\n",
      "911 National smoking ban in RESTAURANTS\n",
      "912 Compliance of ban on smoking in PUBS AND BARS\n",
      "913 National smoking ban in PUBS AND BARS\n",
      "914 Compliance of ban on smoking in PUBLIC TRANSPORT\n",
      "915 National smoking ban in PUBLIC TRANSPORT\n",
      "916 National smoking ban in ALL OTHER INDOOR PUBLIC PLACES\n",
      "917 Compliance with regulations on smoke-free environments (national legislation)\n",
      "918 Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)\n",
      "919 Antenatal care attendees who were positive for syphilis (%)\n",
      "920 Men who have sex with men (MSM) with active syphilis (%)\n",
      "921 Sex workers with active syphilis (%)\n",
      "922 Women accessing antenatal care (ANC) services who were tested for syphilis (%)\n",
      "923 Antenatal care attendees positive for syphilis who received treatment (%)\n",
      "924 Postnatal care visit within two days of birth (in the x years preceding the survey) (%)\n",
      "925 Postnatal care visit within two days of birth (in the three years preceding the survey) (%)\n",
      "926 Postnatal care visit within two days of birth (in the five years preceding the survey) (%)\n",
      "927 Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%)\n",
      "928 Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%)\n",
      "929 Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%)\n",
      "930 Polio immunization coverage among one-year-olds (%)\n",
      "931 Average - taxes as a % of cigarette price - ad valorem excise\n",
      "932 Most sold brand of cigarettes - taxes as a % of price - ad valorem excise\n",
      "933 Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)\n",
      "934 Tax administration: Bans or limits on duty free imports by travellers\n",
      "935 Tax administration: Tax stamps applied on tobacco products\n",
      "936 Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand\n",
      "937 Affordability: Price dispersion: share of cheapest brand price in premium brand price (the higher the % the smaller the gap)\n",
      "938 Affordability: Specific tax component automatically adjusted for inflation (or other)\n",
      "939 Cheapest brand of cigarettes - currency reported\n",
      "940 Most sold brand of cigarettes - currency reported\n",
      "941 Premium brand of cigarettes - currency reported\n",
      "942 Tobacco excises increased over the survey period\n",
      "943 Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime\n",
      "944 Tax structure: Excise tax proportion of price\n",
      "945 Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)\n",
      "946 Tax structure: Greater reliance on specific tax in mixed excise regime\n",
      "947 Tax structure: Type of excise tax applied\n",
      "948 Tax structure: Uniform excise tax\n",
      "949 Raising taxes on tobacco\n",
      "950 Average - taxes as a % of cigarette price - import duties\n",
      "951 Most sold brand of cigarettes - taxes as a % of price - import duties\n",
      "952 Average - taxes as a % of cigarette price - other taxes\n",
      "953 Most sold brand of cigarettes - taxes as a % of price - other taxes\n",
      "954 Most sold brand of cigarettes - price in currency reported\n",
      "955 Premium brand of cigarettes - price in currency reported\n",
      "956 Premium brand of cigarettes - price in international dollars\n",
      "957 Premium brand of cigarettes - price in US$ at official exchange rates\n",
      "958 Average - taxes as a % of cigarette price - specific excise\n",
      "959 Most sold brand of cigarettes - taxes as a % of price - specific excise\n",
      "960 Average - taxes as a % of cigarette price - total tax\n",
      "961 Most sold brand of cigarettes - taxes as a % of price - total tax\n",
      "962 Average - taxes as a % of cigarette price - value added tax\n",
      "963 Most sold brand of cigarettes - taxes as a % of price - value added tax\n",
      "964 Existence of any national radon activity\n",
      "965 Existence of national radon survey(s)\n",
      "966 National radon concentration levels\n",
      "967 Existence of national radon database\n",
      "968 Data in national radon database\n",
      "969 Existence of national radon action plan\n",
      "970 Existence of national radon regulations\n",
      "971 Radon in building regulations for new buildings\n",
      "972 Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration\n",
      "973 Radon in national drinking-water regulations\n",
      "974 Existence of national reference level for dwellings and buildings with high public occupancy\n",
      "975 Existence of national reference level for buildings with high public occupancy\n",
      "976 Existence of official protocols for radon measurements\n",
      "977 Radon concentration measurements for new buildings\n",
      "978 Radon concentration measurements for existing buildings\n",
      "979 Authorization/accreditation required for official radon measurement providers\n",
      "980 Mandatory preventive measures (new buildings)\n",
      "981 Mandatory mitigation measures if legal value is exceeded (existing buildings)\n",
      "982 Financial support provided for mitigation (existing dwellings)\n",
      "983 Authorization/accreditation required for prevention/mitigation service providers\n",
      "984 Official standards/guidelines for prevention/mitigation\n",
      "985 Existence of training/education on prevention/mitigation\n",
      "986 Existence of national radon risk communication strategy\n",
      "987 Inclusion of radon measurements in property transactions\n",
      "988 Inclusion of radon in national cancer control strategy\n",
      "989 Congenital syphilis rate per 100 000 live births\n",
      "990 Annual tax revenues - currency\n",
      "991 Annual tax revenues - total excise (specific and ad valorem)\n",
      "992 Annual tax revenues - total revenues\n",
      "993 Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies)\n",
      "994 Annual tax revenues - tobacco products included\n",
      "995 Annual tax revenues - value added tax (vat) and other sales taxes\n",
      "996 Annual tax revenues - year\n",
      "997 Intimate partner violence prevalence among ever partnered women (%)\n",
      "998 Non-partner sexual violence prevalence (%)\n",
      "999 Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)\n",
      "1000 Population\n",
      "1001 Income level\n",
      "1002 Number of registered vehicles\n",
      "1003 Estimated number of road traffic deaths\n",
      "1004 Estimated road traffic death rate (per 100 000 population)\n",
      "1005 Existence of a national drink-driving law\n",
      "1006 Definition of drink-driving by BAC\n",
      "1007 Blood Alcohol Concentration (BAC) limit for drivers\n",
      "1008 Attribution of road traffic deaths to alcohol (%)\n",
      "1009 Existence of a national seat-belt law\n",
      "1010 Applicability of seat-belt law to all occupants\n",
      "1011 Seat-belt wearing rate (%)\n",
      "1012 Existence of a national child-restraint law\n",
      "1013 Existence of national speed limits\n",
      "1014 Maximum speed limits\n",
      "1015 Applicability of national motorcycle helmet law to all occupants\n",
      "1016 Law requires helmet to be fastened\n",
      "1017 Existence of a road safety lead agency\n",
      "1018 Existence of a national road safety strategy\n",
      "1019 Availability of funding for national road safety strategy\n",
      "1020 Existence of a formal pre-hospital care system\n",
      "1021 Existence of a universal access telephone number for pre-hospital care\n",
      "1022 Vehicle standards\n",
      "1023 Distribution of road traffic deaths by type of road user (%)\n",
      "1024 Gross national income per capita (Atlas method)\n",
      "1025 Point prevalence (%), alcohol use disorders, 15+ years\n",
      "1026 National survey on substance use among children and adolescents\n",
      "1027 Government unit/official responsible for prevention for substance use\n",
      "1028 Data on substance use disorders disseminated in national annual reports\n",
      "1029 Ministry/office that takes primary responsibility for prevention for substance use\n",
      "1030 Substance use policy at the national level\n",
      "1031 Five years change in international cooperation for prevention for substance use\n",
      "1032 Substance use policy at the national level, level of integration\n",
      "1033 Government unit/official responsible for treatment of substance use disorders\n",
      "1034 Policy documents on the pharmacological treatment of substance use disorders\n",
      "1035 Ministry/office that takes primary responsibility for treatment of substance use disorders\n",
      "1036 Guidelines on the pharmacological treatment of substance use disorders\n",
      "1037 Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders\n",
      "1038 Legislative provision for treatment and rehabilitation of substance use disorders\n",
      "1039 Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders\n",
      "1040 Legislative provision for compulsory treatment\n",
      "1041 Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs\n",
      "1042 Drug courts\n",
      "1043 Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs\n",
      "1044 Programmes diverting clients from the justice system towards treatment\n",
      "1045 Five years change in international cooperation for treatment of substance use disorders\n",
      "1046 Point prevalence (%), drug use disorders, 15+ years\n",
      "1047 Confidentiality of health records on substance use disorders  protected by law\n",
      "1048 Confidentiality of people in treatment for substance use disorders\n",
      "1049 Government unit for substance use disorder treatment\n",
      "1050 Voluntary treatment for people with alcohol use disorders in the criminal justice system\n",
      "1051 Budget line for substance use disorder treatment\n",
      "1052 Voluntary treatment for people with drug use disorders in the criminal justice system\n",
      "1053 Financing method for substance use disorder treatment\n",
      "1054 Compulsory treatment for people with alcohol use disorders in the criminal justice system\n",
      "1055 Compulsory treatment for people with drug use disorders in the criminal justice system\n",
      "1056 Five-year change in government resources for prevention for substance use\n",
      "1057 Governement benefits for persons with substance use disorders\n",
      "1058 Five-year change in government resources for treatment of substance use disorders\n",
      "1059 Government benefits for alcohol use disorders, subsidy or disability pension\n",
      "1060 Financing methods for treatment for alcohol use disorders\n",
      "1061 Government benefits for drug use disorders, subsidy or disability pension\n",
      "1062 Financing methods for treatment for drug use disorders\n",
      "1063 Sector for inpatient detoxification of alcohol use disorders\n",
      "1064 Hypothecated taxes to be spent on prevention and treatment for substance use disorders\n",
      "1065 Age-standardized death rates, alcohol and drug use disorders, per 100 000\n",
      "1066 Sector for inpatient treatment of alcohol dependence\n",
      "1067 Government benefits for people with alcohol use disorders\n",
      "1068 Sector for outpatient treatment of alcohol dependence\n",
      "1069 Government benefits for people with drug use disorders\n",
      "1070 Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions\n",
      "1071 Main sector for treatment for alcohol use disorders\n",
      "1072 Sector for residential long-term rehabilitation of alcohol use disorders\n",
      "1073 Main sector for treatment for drug use disorders\n",
      "1074 Sector for inpatient detoxification of drug use disorders\n",
      "1075 Treatment programmes for children and adolescents with alcohol use disorders\n",
      "1076 Sector for inpatient treatment of drug dependence\n",
      "1077 Treatment programmes for children and adolescents with drug use disorders\n",
      "1078 Sector for outpatient treatment of drug dependence\n",
      "1079 Specialized treatment facilities for substance use disorders\n",
      "1080 Sector for substitution maintenance therapy of opioid dependence\n",
      "1081 Specialized treatment facilities for alcohol use disorders\n",
      "1082 Sector for residential long-term rehabilitation of drug use disorders\n",
      "1083 Specialized treatment facilities for drug use disorders\n",
      "1084 Treatment system for substance use disorders\n",
      "1085 Self-help groups\n",
      "1086 Treatment setting for substance use disorders, most common\n",
      "1087 Main substance at treatment entry\n",
      "1088 Specialized treatment services for drug use disoders and HIV/AIDS\n",
      "1089 Reported treatment coverage for substance dependence\n",
      "1090 Specialized treatment services for substance use disorders and TB\n",
      "1091 Guidelines on pharmacological treatment for substance use disorders\n",
      "1092 Open access services for substance use disorders\n",
      "1093 Pharmacotherapy with methadone\n",
      "1094 Treatment slots for alcohol and drug use disorders, outpatient, per 10 000\n",
      "1095 Pharmacotherapy with buprenorphine\n",
      "1096 Beds for the treatment of substance use disorders, per 100 000\n",
      "1097 Pharmacotherapy with buprenorphine/naloxone\n",
      "1098 Length of stay for inpatient detoxification, days\n",
      "1099 Access restrictions to maintenance treatment\n",
      "1100 Length of stay for inpatient short-term treatment, days\n",
      "1101 Timeframe for maintenance treatment of opioid dependence\n",
      "1102 Length of stay for inpatient long-term residential treatment, days\n",
      "1103 Registration of medications for alcohol dependence and withdrawal\n",
      "1104 Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)\n",
      "1105 Registration of medications for opioid dependence\n",
      "1106 Age-standardized DALYs, alcohol and drug use disorders, per 100 000\n",
      "1107 Timeframe of opioid agonist treatment\n",
      "1108 Registration of medications for opioid withdrawal\n",
      "1109 Methadone used for the treatment of opioid dependence\n",
      "1110 Registration of naloxone for injection for opioid overdose\n",
      "1111 Methadone used for detoxification or maintenance\n",
      "1112 Availability of naloxone\n",
      "1113 Methadone formulation used for the treatment of opiod dependence\n",
      "1114 Screening and brief intervention for substance use in primary health care\n",
      "1115 Buprenorphine used for the treatment of opioid dependence\n",
      "1116 Screening and brief intervention for substance use in antenatal services\n",
      "1117 Buprenorphine used for detoxification or maintenance\n",
      "1118 Recommendations for screening and brief interventions for substance use in primary health care\n",
      "1119 Buprenorphine/naloxone used for the treatment of opioid dependence\n",
      "1120 Recommendations for screening and brief interventions for substance use in antenatal services\n",
      "1121 Buprenorphine/naloxone used for detoxification or maintenance\n",
      "1122 Groups and agencies involved in prevention programs\n",
      "1123 Methadone provision in clinical and community-based settings\n",
      "1124 Prevention programmes for alcohol\n",
      "1125 Buprenorphine provision in clinical and community-based settings\n",
      "1126 Prevention programmes for specific populations for alcohol\n",
      "1127 Buprenorphine/naloxone provision in clinical and community-based settings\n",
      "1128 Prevention programmes for drugs\n",
      "1129 Supervision requirements for methadone administration\n",
      "1130 Prevention programmes for specific populations for drugs\n",
      "1131 Supervision requirements for buprenorphine administration\n",
      "1132 HIV, Hepatitis counselling and treatment availability in specialized facilities and services\n",
      "1133 Supervision requirements for buprenorphine/naloxone administration\n",
      "1134 Programmes readily available\n",
      "1135 Prescription requirements for methadone\n",
      "1136 Standards of treatment and care for public specialized treatment facilities\n",
      "1137 Prescription requirements for buprenorphine\n",
      "1138 Special treatment programmes for gambling disorder\n",
      "1139 Prescription requirements for buprenorphine/naloxone\n",
      "1140 Treatment programmes for women with alcohol use disorders\n",
      "1141 Commencement of treatment with opioid agonists\n",
      "1142 Treatment programmes for women with drug use disorders\n",
      "1143 Pharmacotherapy used for the management of alcohol withdrawal\n",
      "1144 Special housing services for alcohol use disorders\n",
      "1145 Pharmacotherapy used for the management of benzodiazepine withdrawal\n",
      "1146 Special housing services for drug use disorders\n",
      "1147 Psychoactive substance causing entry into treatment\n",
      "1148 Pharmacotherapy used for the management of cannabis withdrawal\n",
      "1149 Employment services for alcohol use disorders\n",
      "1150 Essential list of medicines\n",
      "1151 Employment services for drug use disorders\n",
      "1152 Essential list of medicines, pharmacotherapy for substance use disorders\n",
      "1153 Open access interventions for alcohol\n",
      "1154 Government unit for substance use disorder prevention\n",
      "1155 Open access interventions for drugs\n",
      "1156 Budget line for substance use disorder prevention\n",
      "1157 Health professionals providing treatment for alcohol and drug use disorders\n",
      "1158 Funding method for substance use disorder prevention\n",
      "1159 Standards of care for professionals providing treatment for alcohol and drug use disorders\n",
      "1160 Prevention activities for substance use disorders, main focus\n",
      "1161 Educational attainment in prevention\n",
      "1162 Programmes for the prevention of substance use disorders for special populations\n",
      "1163 Postgraduate training programme in prevention\n",
      "1164 Screening and brief interventions for substance use and substance use disorders\n",
      "1165 Continuing professional development in prevention\n",
      "1166 Harm reduction programmes for IDUs\n",
      "1167 Educational attainment in treatment\n",
      "1168 Epidemiological data collection system for substance use disorders\n",
      "1169 Health professionals mostly involved in treatment of substance use disorders\n",
      "1170 Postgraduate training programme in treatment\n",
      "1171 Clinical supervision of health care staff\n",
      "1172 Continuing professional development in treatment\n",
      "1173 Standards of care for health professionals\n",
      "1174 Epidemiological data collection for substance use\n",
      "1175 Standards of care for health professionals, maintenance\n",
      "1176 Service delivery data collection for substance use\n",
      "1177 Standards of care for health professionals, human rights\n",
      "1178 Regular reports on epidemiological and service delivery data for substance use\n",
      "1179 NGOs for alcohol use disorders\n",
      "1180 System of monitoring alcohol involvement in forensic pathology\n",
      "1181 NGOs for drug use disorders\n",
      "1182 System of monitoring drugs involvement in forensic pathology\n",
      "1183 Self-help groups for substance use disorders\n",
      "1184 Epidemiological data collection system for substance use among children and adolescents\n",
      "1185 Groups and agencies for the prevention of substance use disorders\n",
      "1186 Epidemiological data collection system for substance use among children and adolescents\n",
      "1187 Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)\n",
      "1188 Treatment programmes for children and adolescents with alcohol use disorders\n",
      "1189 Service delivery data collection system for substance use disorders\n",
      "1190 Treatment programmes for children and adolescents with drug use disorders\n",
      "1191 Alcohol, consumption of pure alcohol by type of beverage (%)\n",
      "1192 Alcohol, consumption of pure alcohol by type of beverage (%)\n",
      "1193 Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)\n",
      "1194 Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)\n",
      "1195 Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average\n",
      "1196 Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average\n",
      "1197 Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010\n",
      "1198 Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010\n",
      "1199 Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)\n",
      "1200 Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)\n",
      "1201 Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol\n",
      "1202 Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol\n",
      "1203 Alcohol, tourist consumption (in litres of pure alcohol)\n",
      "1204 Alcohol, tourist consumption (in litres of pure alcohol)\n",
      "1205 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)\n",
      "1206 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)\n",
      "1207 Alcohol, abstainers lifetime (%)\n",
      "1208 Alcohol, abstainers lifetime (%)\n",
      "1209 Abstainers (15-19 years), lifetime (%)\n",
      "1210 Alcohol, abstainers past 12 months (%)\n",
      "1211 Alcohol, abstainers past 12 months (%)\n",
      "1212 Abstainers (15-19 years), past 12 months (%)\n",
      "1213 Alcohol, consumers past 12 months (%)\n",
      "1214 Alcohol, consumers past 12 months (%)\n",
      "1215 Alcohol, former drinkers (%)\n",
      "1216 Alcohol, former drinkers (%)\n",
      "1217 Alcohol, heavy episodic drinking (population) past 30 days (%)\n",
      "1218 Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)\n",
      "1219 Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)\n",
      "1220 Alcohol, patterns of drinking score\n",
      "1221 Alcohol, patterns of drinking score\n",
      "1222 Age-standardized DALYs, alcohol use disorders, per 100,000\n",
      "1223 Age-standardized DALYs, breast cancer, per 100,000\n",
      "1224 Age-standardized DALYs, colon and rectum cancers, per 100,000\n",
      "1225 Age-standardized DALYs, diabetes mellitus, per 100,000\n",
      "1226 Age-standardized DALYs, drownings, per 100,000\n",
      "1227 Age-standardized DALYs, falls, per 100,000\n",
      "1228 Age-standardized DALYs, fires, per 100,000\n",
      "1229 Age-standardized DALYs, ischaemic heart disease, per 100,000\n",
      "1230 Age-standardized DALYs, liver cancer, per 100,000\n",
      "1231 Age-standardized DALYs, liver cirrhosis, per 100,000\n",
      "1232 Age-standardized DALYs, mouth and oropharynx cancer, per 100,000\n",
      "1233 Age-standardized DALYs, oesophagus cancer, per 100,000\n",
      "1234 Age-standardized DALYs, poisoning, per 100,000\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1235 Age-standardized DALYs, prematurity and low birth rate, per 100,000\n",
      "1236 Age-standardized DALYs, road traffic accidents, per 100,000\n",
      "1237 Age-standardized DALYs, self-inflicted injury, per 100,000\n",
      "1238 Age-standardized DALYs, other unintentional injuries, per 100,000\n",
      "1239 Age-standardized DALYs, violence, per 100,000\n",
      "1240 Age-standardized death rates, alcohol use disorders, per 100,000\n",
      "1241 Age-standardized death rates, breast cancer, per 100,000\n",
      "1242 Age-standardized death rates, colon and rectum cancers, per 100,000\n",
      "1243 Age-standardized death rates, diabetes mellitus, per 100,000\n",
      "1244 Age-standardized death rates, drownings, per 100,000\n",
      "1245 Age-standardized death rates, falls, per 100,000\n",
      "1246 Age-standardized death rates, fires, per 100,000\n",
      "1247 Age-standardized death rates, ischaemic heart disease, per 100,000\n",
      "1248 Age-standardized death rates, liver cancer, per 100,000\n",
      "1249 Age-standardized death rates, liver cirrhosis, per 100,000\n",
      "1250 Age-standardized death rates, mouth and oropharynx cancer, per 100,000\n",
      "1251 Age-standardized death rates, oesophagus cancer, per 100,000\n",
      "1252 Age-standardized death rates, poisoning, per 100,000\n",
      "1253 Age-standardized death rates, prematurity and low birth rate, per 100,000\n",
      "1254 Age-standardized death rates, road traffic accidents, per 100,000\n",
      "1255 Age-standardized death rates, self-inflicted injury, per 100,000\n",
      "1256 Age-standardized death rates, other unintentional injuries, per 100,000\n",
      "1257 Age-standardized death rates, violence, per 100,000\n",
      "1258 Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000\n",
      "1259 Liver cirrhosis, age-standardized death rates (15+), per 100,000 population\n",
      "1260 Liver cirrhosis, age-standardized death rates (15+), per 100,000 population\n",
      "1261 Age-standardized death rates (15+ years), poisoning, per 100,000\n",
      "1262 Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population\n",
      "1263 Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population\n",
      "1264 Age-standardized death rates (15+ years), violence, per 100,000\n",
      "1265 Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI\n",
      "1266 Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI\n",
      "1267 Alcohol use disorders (15+), 12 month prevalence (%) with 95%\n",
      "1268 Alcohol use disorders (15+), 12 month prevalence (%) with 95%\n",
      "1269 Alcoholic psychosis, incidence, per 100,000\n",
      "1270 Alcoholic psychosis, incidence, per 100,000\n",
      "1271 Cautions and arrests for drink-driving, per 100,000 population\n",
      "1272 Cautions and arrests for drink-driving, per 100,000 population\n",
      "1273 Hospital discharges, alcohol-related injuries and poisoning, per 100,000\n",
      "1274 Hospital discharges, alcoholic liver disease, per 100,000\n",
      "1275 Perceived trend in alcohol-related harm and consequences\n",
      "1276 Treatment admissions (inpatient), alcohol dependence, per 100,000\n",
      "1277 Treatment admissions (inpatient), alcoholic psychosis, per 100,000\n",
      "1278 Alcohol-related road traffic crashes, per 100,000 population\n",
      "1279 Alcohol-related road traffic crashes, per 100,000 population\n",
      "1280 Alcohol-related road traffic crashes (% of all traffic crashes)\n",
      "1281 Alcohol-related road traffic crashes (% of all traffic crashes)\n",
      "1282 Alcohol-related injury mortality, per 1,000\n",
      "1283 Alcohol-related disease mortality, per 100,000 (15+ years)\n",
      "1284 Alcoholic excise tax revenue as a per cent of government revenue\n",
      "1285 Alcoholic excise tax revenue as a per cent of government revenue\n",
      "1286 Annual revenues from alcohol excise tax in millions US$\n",
      "1287 Annual revenues from alcohol excise tax in millions US$\n",
      "1288 Alcohol expenditure as a per cent of total household expenditure\n",
      "1289 Alcohol expenditure as a per cent of total household expenditure\n",
      "1290 Social costs of alcohol use in millions US$\n",
      "1291 Social costs of alcohol use in millions US$\n",
      "1292 Adopted written national policy on alcohol\n",
      "1293 Adopted written national policy on alcohol\n",
      "1294 Alcoholic beverage legally defined\n",
      "1295 Alcohol use is banned\n",
      "1296 Alcohol use is banned\n",
      "1297 National legislation to prevent illegal alcohol\n",
      "1298 National legislation to prevent illegal alcohol\n",
      "1299 Advertising restrictions on national television\n",
      "1300 Advertising restrictions on national television\n",
      "1301 Advertising restrictions on cable television\n",
      "1302 Advertising restrictions on cable television\n",
      "1303 Advertising restrictions on national radio\n",
      "1304 Advertising restrictions on national radio\n",
      "1305 Advertising restrictions on local radio\n",
      "1306 Advertising restrictions on local radio\n",
      "1307 Advertising restrictions in print media\n",
      "1308 Advertising restrictions in print media\n",
      "1309 Advertising restrictions at cinemas\n",
      "1310 Advertising restrictions at cinemas\n",
      "1311 Advertising restrictions on billboards\n",
      "1312 Advertising restrictions on billboards\n",
      "1313 Advertising restrictions at point-of-sale\n",
      "1314 Advertising restrictions at point-of-sale\n",
      "1315 Advertising restrictions on the internet\n",
      "1316 Advertising restrictions on the internet\n",
      "1317 Restrictions on product placement on national television\n",
      "1318 Restrictions on product placement on national television\n",
      "1319 Restrictions on product placement on cable television\n",
      "1320 Restrictions on product placement on cable television\n",
      "1321 Age limits on-premise service\n",
      "1322 Age limits on-premise service\n",
      "1323 Minimum legal drinking age\n",
      "1324 Legal blood alcohol concentration (BAC) limits\n",
      "1325 Random breath testing (RBT) use\n",
      "1326 Random breath testing (RBT) use\n",
      "1327 Prices for alcoholic beverages (average, US$)\n",
      "1328 Prices for alcoholic beverages (average, US$)\n",
      "1329 Off-premise sales restrictions on days\n",
      "1330 Off-premise sales restrictions on days\n",
      "1331 Off-premise sales restrictions on hours\n",
      "1332 Off-premise sales restrictions on hours\n",
      "1333 Off-premise sales restrictions on places\n",
      "1334 Off-premise sales restrictions on places\n",
      "1335 Off-premise sales restrictions on outlet density\n",
      "1336 Off-premise sales restrictions on outlet density\n",
      "1337 Off-premise sales restrictions at specific events\n",
      "1338 Off-premise sales restrictions at specific events\n",
      "1339 Off-premise sales restrictions at petrol stations\n",
      "1340 Off-premise sales restrictions at petrol stations\n",
      "1341 On-premise sales restrictions on days\n",
      "1342 On-premise sales restrictions on days\n",
      "1343 On-premise sales restrictions on hours\n",
      "1344 On-premise sales restrictions on hours\n",
      "1345 On-premise sales restrictions on places\n",
      "1346 On-premise sales restrictions on places\n",
      "1347 On-premise sales restrictions on outlet density\n",
      "1348 On-premise sales restrictions on outlet density\n",
      "1349 On-premise sales restrictions at specific events\n",
      "1350 On-premise sales restrictions at specific events\n",
      "1351 On-premise sales restrictions to intoxicated persons\n",
      "1352 On-premise sales restrictions to intoxicated persons\n",
      "1353 Restrictions on sponsorship of sporting events\n",
      "1354 Restrictions on sponsorship of sporting events\n",
      "1355 Restrictions on sponsorship of youth events\n",
      "1356 Restrictions on sponsorship of youth events\n",
      "1357 Restrictions on sales promotion from producers (parties, events)\n",
      "1358 Restrictions on sales promotion from producers (parties, events)\n",
      "1359 Restrictions on sales promotion from retailers (sales below cost)\n",
      "1360 Restrictions on sales promotion from retailers (sales below cost)\n",
      "1361 Restrictions on sales promotion from owners of pubs and bars (alcohol for free)\n",
      "1362 Restrictions on sales promotion from owners of pubs and bars (alcohol for free)\n",
      "1363 Government monopoly on production\n",
      "1364 Government monopoly on production\n",
      "1365 Government monopoly on retail sales\n",
      "1366 Government monopoly on retail sales\n",
      "1367 Licence required for production\n",
      "1368 Licence required for production\n",
      "1369 Licence required for retail sales\n",
      "1370 Licence required for retail sales\n",
      "1371 Excise tax as a per cent of the retail price of alcoholic beverages\n",
      "1372 Excise tax as a per cent of the retail price of alcoholic beverages\n",
      "1373 Excise duty (average) per hectolitre in Euros\n",
      "1374 Excise duty (average) per hectolitre in Euros\n",
      "1375 Excise tax as a per cent of the total retail price for 1 litre of pure alcohol\n",
      "1376 Excise tax as a per cent of the total retail price for 1 litre of pure alcohol\n",
      "1377 Duty paid or excise stamp on alcohol container\n",
      "1378 Duty paid or excise stamp on alcohol container\n",
      "1379 Excise tax on alcoholic beverages\n",
      "1380 Excise tax on alcoholic beverages\n",
      "1381 Value-added tax (VAT) on alcohol (%)\n",
      "1382 Value-added tax (VAT) on alcohol (%)\n",
      "1383 Restrictions on alcohol use in public places\n",
      "1384 Restrictions on alcohol use in public places\n",
      "1385 Health warning labels on alcohol advertising\n",
      "1386 Health warning labels on alcohol advertising\n",
      "1387 Health warning labels on alcohol containers\n",
      "1388 Health warning labels on alcohol containers\n",
      "1389 Awareness activities\n",
      "1390 Awareness activities\n",
      "1391 Information, education, prevention\n",
      "1392 National drinking guidelines\n",
      "1393 Standard drink measures, in grams per unit\n",
      "1394 Standard drink measures, in grams per unit\n",
      "1395 Monitoring\n",
      "1396 Interventions, projects, training\n",
      "1397 Treatment, services\n",
      "1398 Surveys, research\n",
      "1399 Counselling\n",
      "1400 Production in 1000s hectolitres\n",
      "1401 Imports in 1000s hectolitres\n",
      "1402 Sales of beer in 1000s hectolitres\n",
      "1403 Exports of beer (barley) in 1000s hectolitres\n",
      "1404 Perceived trend in production\n",
      "1405 Perceived trend in imports\n",
      "1406 Perceived trend in sales\n",
      "1407 Perceived trend in exports\n",
      "1408 Sales of wine in 1000s hectolitres\n",
      "1409 Sales of spirits in 1000s hectolitres\n",
      "1410 Exports of wine (grape) in 1000s hectolitres\n",
      "1411 Exports of spirits in 1000s hectolitres\n",
      "1412 Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)\n",
      "1413 Total (recorded+unrecorded) alcohol per capita (15+) consumption\n",
      "1414 Age-standardized DALYs, cerebrovascular disease, per 100,000\n",
      "1415 Age-standardized death rates, cerebrovascular disease, per 100,000\n",
      "1416 Central coordinating entity for alcohol policy implementation\n",
      "1417 Central coordinating entity for alcohol policy implementation\n",
      "1418 Framework of national alcohol policy\n",
      "1419 Framework of national alcohol policy\n",
      "1420 Level of adoption of national alcohol policy\n",
      "1421 Level of adoption of national alcohol policy\n",
      "1422 Sectors represented in national alcohol policy\n",
      "1423 Sectors represented in national alcohol policy\n",
      "1424 Cautions and arrests for public drunkenness, per 100,000 population\n",
      "1425 Cautions and arrests for public drunkenness, per 100,000 population\n",
      "1426 Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)\n",
      "1427 Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)\n",
      "1428 Adopted written national policy on alcohol, year adopted\n",
      "1429 Adopted written national policy on alcohol, year revised\n",
      "1430 Age limits off-premise sales\n",
      "1431 Age limits off-premise sales\n",
      "1432 Consumer information on alcohol and health at points of sale\n",
      "1433 Educational programmes involving target groups in school curriculum\n",
      "1434 Brief interventions as health promotion/disease prevention\n",
      "1435 Server training on a regular basis\n",
      "1436 Data collection on alcohol-related health indicators\n",
      "1437 System for monitoring alcohol-related harm\n",
      "1438 National treatment policy for alcohol use disorders\n",
      "1439 Persons with alcohol use disorders receiving treatment (%)\n",
      "1440 Designation of alcohol tax revenues to health services\n",
      "1441 National surveys on drink-driving\n",
      "1442 Public-funded alcohol research/monitoring programmes\n",
      "1443 Public funds designated for alcohol research/monitoring programmes, in Euros\n",
      "1444 Community-based interventions/projects involving stakeholders\n",
      "1445 Interventions/projects actively involving young people and civil society\n",
      "1446 Training in screening and brief interventions for alcohol problems\n",
      "1447 Counselling to children in families with alcohol problems\n",
      "1448 Counselling to pregnant women with alcohol problems\n",
      "1449 Prevention/counselling at workplaces for those with alcohol problems\n",
      "1450 Advertising restrictions on social media\n",
      "1451 Advertising restrictions on social media\n",
      "1452 Restrictions on product placement in films/movies\n",
      "1453 Restrictions on product placement in films/movies\n",
      "1454 Importance of measures for enhancing compliance with age limits\n",
      "1455 Importance of measures for enhancing compliance with age limits\n",
      "1456 Government support for community action\n",
      "1457 Government support for community action\n",
      "1458 Community-based interventions involving stakeholders\n",
      "1459 Community-based interventions involving stakeholders\n",
      "1460 National guidelines for implementing effective community-based interventions\n",
      "1461 National guidelines for implementing effective community-based interventions\n",
      "1462 National alcohol policy specifically involves young people activities\n",
      "1463 National alcohol policy specifically involves young people activities\n",
      "1464 Penalties for drink driving\n",
      "1465 Penalties for drink driving\n",
      "1466 Sobriety checkpoints\n",
      "1467 Sobriety checkpoints\n",
      "1468 Detection of marketing infringements\n",
      "1469 Detection of marketing infringements\n",
      "1470 Penalties for marketing infringements\n",
      "1471 Price measures\n",
      "1472 Price measures\n",
      "1473 Level of taxation adjusted for inflation\n",
      "1474 Level of taxation adjusted for inflation\n",
      "1475 New types of alcoholic beverages emerging\n",
      "1476 New types of alcoholic beverages emerging\n",
      "1477 Consumer information about calories, additives, etc on containers\n",
      "1478 Consumer information about calories, additives, etc on containers\n",
      "1479 Number of standard alcoholic drinks displayed on containers\n",
      "1480 Number of standard alcoholic drinks displayed on containers\n",
      "1481 Alcohol content displayed on containers\n",
      "1482 Alcohol content displayed on containers\n",
      "1483 Action Plan for implementation of alcohol policy\n",
      "1484 Action Plan for implementation of alcohol policy\n",
      "1485 Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)\n",
      "1486 Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)\n",
      "1487 Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI\n",
      "1488 Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI\n",
      "1489 Alcohol-attributable Years of Life Lost (YLL) score\n",
      "1490 Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)\n",
      "1491 Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)\n",
      "1492 Alcohol-attributable fractions (15+), road traffic crash deaths (%)\n",
      "1493 Alcohol-attributable fractions (15+), road traffic crash deaths (%)\n",
      "1494 Alcohol-attributable fractions, all-cause deaths (%)\n",
      "1495 Alcohol-attributable fractions, all-cause deaths (%)\n",
      "1496 Alcohol, regional prevalence of alcohol dependence (%)\n",
      "1497 Alcohol, regional prevalence of alcohol dependence (%)\n",
      "1498 Alcohol, regional prevalence of alcohol use disorders (%)\n",
      "1499 Alcohol, regional prevalence of alcohol use disorders (%)\n",
      "1500 Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025\n",
      "1501 Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025\n",
      "1502 Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI\n",
      "1503 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1504 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1505 Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1506 Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1507 Alcohol, average daily intake in grams among drinkers with 95%CI\n",
      "1508 Alcohol, average daily intake in grams among drinkers with 95%CI\n",
      "1509 Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016\n",
      "1510 Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016\n",
      "1511 Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI\n",
      "1512 Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI\n",
      "1513 Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI\n",
      "1514 15-19 years old heavy episodic drinkers (population), % with 95%CI\n",
      "1515 15-19 years old heavy episodic drinkers (population), % with 95%CI\n",
      "1516 15-19 years old heavy episodic drinkers (drinkers only), %\n",
      "1517 15-19 years old abstainers, lifetime (%)\n",
      "1518 15-19 years old abstainers, lifetime (%)\n",
      "1519 15-19 years old former drinkers (%)\n",
      "1520 15-19 years old former drinkers (%)\n",
      "1521 15-19 years old, current drinkers (%)\n",
      "1522 15-19 years old, current drinkers (%)\n",
      "1523 15-19 years old total alcohol consumption in litres of pure alcohol\n",
      "1524 15-19 years old total alcohol consumption in litres of pure alcohol\n",
      "1525 National guidelines for the prevention and reduction of alcohol-related harm in schools\n",
      "1526 National guidelines for alcohol problem prevention and counselling at workplaces\n",
      "1527 National guidelines for alcohol problem prevention and counselling at workplaces\n",
      "1528 Workplace representatives nationally involved to prevent and address alcohol-related harm\n",
      "1529 Workplace representatives nationally involved to prevent and address alcohol-related harm\n",
      "1530 Server training\n",
      "1531 Server training\n",
      "1532 Legal obligation for schools to include alcohol use prevention\n",
      "1533 Legal obligation for schools to include alcohol use prevention\n",
      "1534 Legal obligation for schools to interact with parents regarding education and well-being\n",
      "1535 Legal obligation for schools to interact with parents regarding education and well-being\n",
      "1536 Legislation on alcohol testing at workplaces\n",
      "1537 Legislation on alcohol testing at workplaces\n",
      "1538 Standard drink defined\n",
      "1539 Standard drink defined\n",
      "1540 National systems for monitoring alcohol consumption and harms\n",
      "1541 National systems for monitoring alcohol consumption and harms\n",
      "1542 Regular reports from national monitoring systems\n",
      "1543 Regular reports from national monitoring systems\n",
      "1544 Comprehensive and regular reporting of alcohol situation\n",
      "1545 Comprehensive and regular reporting of alcohol situation\n",
      "1546 Clinical guidelines for brief interventions\n",
      "1547 Clinical guidelines for brief interventions\n",
      "1548 National surveys on adult alcohol consumption\n",
      "1549 National surveys on adult alcohol consumption\n",
      "1550 National surveys on youth alcohol consumption\n",
      "1551 National surveys on youth alcohol consumption\n",
      "1552 National surveys on heavy espisodic drinking\n",
      "1553 National surveys on heavy espisodic drinking\n",
      "1554 Data collection on Foetal Alcohol Syndome\n",
      "1555 Data collection on Foetal Alcohol Syndome\n",
      "1556 Data collected on harm from alcohol at workplace\n",
      "1557 Data collected on harm from alcohol at workplace\n",
      "1558 Level of enforcement of BAC limits\n",
      "1559 15-years old any alcoholic beverage consumed in past 12 months, (%)\n",
      "1560 15-years old any alcoholic beverage consumed in past 12 months, (%)\n",
      "1561 15-years old first drink at 13 years or younger, (%)\n",
      "1562 15-years old first drink at 13 years or younger, (%)\n",
      "1563 15-years old any alcoholic beverage consumed in past 30 days, (%)\n",
      "1564 15-years old any alcoholic beverage consumed in past 30 days, (%)\n",
      "1565 15-years old, any alcoholic beverage consumed at least once a week, (%)\n",
      "1566 15-years old, any alcoholic beverage consumed at least once a week, (%)\n",
      "1567 13-15-years old any alcoholic beverage consumed in past 30 days, (%)\n",
      "1568 13-15-years old any alcoholic beverage consumed in past 30 days, (%)\n",
      "1569 13-15-years old first drink before age 14, (%)\n",
      "1570 13-15-years old first drink before age 14, (%)\n",
      "1571 Alcohol-related road traffic crashes with fatalities, per 100,000  population\n",
      "1572 Alcohol-related road traffic crashes with fatalities, per 100,000  population\n",
      "1573 Alcohol-related crimes (% of all crimes)\n",
      "1574 Alcohol-related crimes (% of all crimes)\n",
      "1575 National drinking guidelines\n",
      "1576 Graduated licensing\n",
      "1577 National legislation to prevent illegal alcohol sales\n",
      "1578 Penalties for drink driving, repeated offense\n",
      "1579 Licensing required for exports of alcoholic beverages\n",
      "1580 Licensing required for imports of alcoholic beverages\n",
      "1581 Licensing required for wholesale/distribution of alcoholic beverages\n",
      "1582 Licenses issued for production, change since 2010\n",
      "1583 Licenses issued for retail sale, change since 2010\n",
      "1584 Licenses issued for wholesale/distribution, change since 2010\n",
      "1585 Monopoly on exports of alcoholic beverages\n",
      "1586 Monopoly on imports of alcoholic beverages\n",
      "1587 Monopoly on wholesale /distribution of alcoholic beverages\n",
      "1588 Health warning labels on pregnancy\n",
      "1589 Health warning labels on under-age drinking\n",
      "1590 Health warning labels on drink-driving\n",
      "1591 Legal requirement for size of health warning labels\n",
      "1592 Cancer, age-standardized death rates (15+), per 100,000 population\n",
      "1593 Alcohol-attributable fractions (15+), cancer deaths\n",
      "1594 National system of epidemiological data collection for alcohol use\n",
      "1595 National system of data collection based on health service delivery\n",
      "1596 Report with epidemiological data on lcohol use and AUDs\n",
      "1597 Report with data from health services on alcohol use and AUDs\n",
      "1598 National organization for monitoring alcohol\n",
      "1599 Taxation of ethanol production\n",
      "1600 Ethanol tax deducted from excise tax\n",
      "1601 Tax incentives for production low/no alcohol content beer\n",
      "1602 Tax incentives for production of other alcoholic beverages\n",
      "1603 Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2020 and 2025\n",
      "1604 Heavy episodic drinking (youth 15 -19 years) past 30 days (%)\n",
      "1605 Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)\n",
      "1606 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1607 Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1608 Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1609 Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI\n",
      "1610 Alcohol, tourist consumption (in litres of pure alcohol)\n",
      "1611 Alcohol, tourist consumption (in litres of pure alcohol)\n",
      "1612 Alcohol, regional alcohol per capita (15+) consumption (in litres of pure alcohol)\n",
      "1613 Regional prevalence, AAFs (15+), liver cirrhosis deaths (%)\n",
      "1614 Regional prevalence, AAFs (15+), road traffic crash deaths (%)\n",
      "1615 Regional prevalence, AAFs (15+), cancer\n",
      "1616 Regional prevalence, AAFs ,all-cause deaths (%)\n",
      "1617 Average price 500 mls Beer in US$\n",
      "1618 Average price 750 mls Wine in US$\n",
      "1619 Average price 500 mls Spirits in US$\n",
      "1620 Births attended by skilled health personnel (in the two or three years preceding the survey) (%)\n",
      "1621 Births attended by skilled health personnel (in the five years preceding the survey) (%)\n",
      "1622 Number of deaths attributed to non-communicable diseases, by type of disease and sex\n",
      "1623 Ambient and household air pollution attributable death rate (per 100 000 population)\n",
      "1624 Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized)\n",
      "1625 Completeness of cause-of-death data (%)\n",
      "1626 Estimated direct deaths from major conflicts (per 100 000 population)\n",
      "1627 Average death rate due to natural disasters (per 100 000 population)\n",
      "1628 Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)\n",
      "1629 New HIV infections (per 1000 uninfected population)\n",
      "1630 Average of 13 International Health Regulations core capacity scores\n",
      "1631 Reported number of people requiring interventions against NTDs\n",
      "1632 Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US$), by recipient\n",
      "1633 Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country\n",
      "1634 Concentrations of fine particulate matter (PM2.5)\n",
      "1635 Mortality rate attributed to unintentional poisoning (per 100 000 population)\n",
      "1636 Skilled health professionals density (per 10 000 population)\n",
      "1637 Crude suicide rates (per 100 000 population)\n",
      "1638 Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)\n",
      "1639 Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%)\n",
      "1640 Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%)\n",
      "1641 Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%)\n",
      "1642 Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%)\n",
      "1643 Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%)\n",
      "1644 Participation rate in organized learning (one year before the official primary entry age) (%)\n",
      "1645 Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%)\n",
      "1646 Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%)\n",
      "1647 Proportion of countries that have conducted at least one population and housing census in the last 10 years (%)\n",
      "1648 Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%)\n",
      "1649 Percentage of children under 15 years exposed to second-hand smoke\n",
      "1650 Second-hand smoke attributable DALYs ('000) in children under 5 years\n",
      "1651 Second-hand smoke  attributable DALYs per 100'000 children under 5 years\n",
      "1652 Percentage of women (15+ years) exposed to second-hand smoke\n",
      "1653 Percentage of men (15+ years) exposed to second-hand smoke\n",
      "1654 Second-hand smoke attributable deaths\n",
      "1655 Second-hand smoke attributable DALYs ('000)\n",
      "1656 Second-hand smoke attributable deaths per 100'000 capita\n",
      "1657 Second-hand smoke attributable DALYs per 100'000 capita\n",
      "1658 Second-hand smoke attributable deaths ('000) in children under 5 years\n",
      "1659 Second-hand smoke  attributable deaths per 100'000 children under 5 years\n",
      "1660 Proportion of population below the international poverty line of US$1.90 per day (%)\n",
      "1661 Proportion of women aged 20-24 years who were married or in a union by age 15 (%)\n",
      "1662 Proportion of women aged 20-24 years who were married or in a union by age 18 (%)\n",
      "1663 Stunting prevalence in children aged < 5 years (%)\n",
      "1664 Existence of national regulation\n",
      "1665 Existence of subnational regulation\n",
      "1666 Year of national implementation of regulation\n",
      "1667 Access restrictions\n",
      "1668 Restriction and inspection of facilities\n",
      "1669 Information requirements\n",
      "1670 Safety requirements\n",
      "1671 Training requirements\n",
      "1672 Tuberculosis treatment coverage\n",
      "1673 New cases tested for RR-/MDR-TB (%)\n",
      "1674 Previously treated cases tested for RR-/MDR-TB (%)\n",
      "1675 Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)\n",
      "1676 Laboratories providing drug susceptibility testing (DST) (per 5 million population)\n",
      "1677 Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)\n",
      "1678 Treatment success rate for patients treated for MDR-TB (%)\n",
      "1679 Cases started on MDR-TB treatment\n",
      "1680 Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases\n",
      "1681 Treatment success rate: new TB cases\n",
      "1682 Tuberculosis - new and relapse cases\n",
      "1683 Total number of notified TB cases\n",
      "1684 Treatment success rate: previously treated TB cases\n",
      "1685 Treatment success rate: HIV-positive TB cases\n",
      "1686 Treatment success rate: XDR-TB cases\n",
      "1687 Confirmed cases of MDR-TB started treatment for MDR-TB (%)\n",
      "1688 Number of incident tuberculosis cases\n",
      "1689 Number of incident tuberculosis cases in children aged 0 - 14\n",
      "1690 Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)\n",
      "1691 Number of incident tuberculosis cases,  (HIV-positive cases)\n",
      "1692 Estimated MDR-TB cases among notified pulmonary TB cases\n",
      "1693 Number of deaths due to tuberculosis, excluding HIV\n",
      "1694 Number of prevalent tuberculosis cases\n",
      "1695 Tuberculosis effective treatment coverage (%)\n",
      "1696 HIV-positive TB patients on ART (antiretroviral therapy) (%)\n",
      "1697 HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)\n",
      "1698 TB patients with known HIV status (%)\n",
      "1699 Tested TB patients HIV-positive (%)\n",
      "1700 Confirmed cases of MDR-TB\n",
      "1701 New or unknown treatment history cases: Pulmonary, clinically diagnosed\n",
      "1702 New cases: extrapulmonary\n",
      "1703 New or unknown treatment history cases: Pulmonary, bacteriologically confirmed\n",
      "1704 New cases: other\n",
      "1705 New cases: pulmonary smear-negative\n",
      "1706 New cases: Pulmonary, smear-negative/unknown/not done and other new cases\n",
      "1707 New cases: Pulmonary, smear-positive\n",
      "1708 New cases: pulmonary smear unknown/not done\n",
      "1709 Treatment history unknown\n",
      "1710 Previously treated  cases, excluding relapse\n",
      "1711 Retreatment cases: other\n",
      "1712 Relapse cases (pre-2013 definition)\n",
      "1713 Relapse cases: Pulmonary, clinically diagnosed\n",
      "1714 Relapse cases: extrapulmonary\n",
      "1715 Relapse cases: Pulmonary, bacteriologically confirmed\n",
      "1716 Retreatment cases: treatment after default (pulmonary smear and/or culture positive)\n",
      "1717 Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)\n",
      "1718 Confirmed cases of RR-/MDR-TB\n",
      "1719 Second-line drug susceptibility testing (DST) available\n",
      "1720 Tuberculosis - new and relapse cases\n",
      "1721 Total fertility rate (per woman)\n",
      "1722 Deaths attributable to the environment\n",
      "1723 Total environment  attributable DALYs per 100'000 children under 5 years\n",
      "1724 Deaths attributable to the environment in children under 5 years (%)\n",
      "1725 DALYs attributable to the environment in children under 5 years (%)\n",
      "1726 Age-standardized deaths attributable to the environment (per 100 000 population)\n",
      "1727 Disability-adjusted life years (DALYs) attributable to the environment\n",
      "1728 Age-standardized DALYs attributable to the environment (per 100 000 population)\n",
      "1729 Deaths attributable to the environment (%)\n",
      "1730 Disability-adjusted life years (DALYs) attributable to the environment (%)\n",
      "1731 Total environment attributable deaths ('000) in children under 5 years\n",
      "1732 Total environment  attributable deaths per 100'000 children under 5 years\n",
      "1733 Total environment attributable DALYs ('000) in children under 5 years\n",
      "1734 Under-five mortality rate (deaths per 1000 live births)\n",
      "1735 Primary data availability for UHC Service Coverage Index (SDG 3.8.1) (%)\n",
      "1736 Compliance with international health regulations\n",
      "1737 UHC Service Coverage Index (SDG 3.8.1)\n",
      "1738 UHC Service Coverage sub-index on service capacity and access\n",
      "1739 UHC Service Coverage sub-index on infectious diseases\n",
      "1740 UHC Service Coverage sub-index on noncommunicable diseases\n",
      "1741 UHC Service Coverage sub-index on reproductive, maternal, newborn and child health\n",
      "1742 Children aged <5 years with diarrhoea receiving ORS (%)\n",
      "1743 Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%)\n",
      "1744 Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%)\n",
      "1745 UV radiation\n",
      "1746 UV radiation attributable deaths\n",
      "1747 UV radiation attributable DALYs ('000)\n",
      "1748 UV radiation attributable deaths per 100'000 capita\n",
      "1749 UV radiation attributable DALYs per 100'000 capita\n",
      "1750 Lifetime prevalence of child emotional abuse (%)\n",
      "1751 Lifetime prevalence of child physical neglect (%)\n",
      "1752 Lifetime prevalence of child physical abuse (%)\n",
      "1753 Lifetime prevalence of child sexual abuse (%)\n",
      "1754 Extent of implementation of  mental health services for victims of all types of violence\n",
      "1755 Child maltreatment: Extent of implementation of home-visiting programmes\n",
      "1756 Extent of implementation of child protection services\n",
      "1757 Elder abuse: Extent of implementation  of caregiver-support programmes\n",
      "1758 Intimate partner violence: Extent of implementation  of dating violence prevention programmes\n",
      "1759 Extent of implementation of medico-legal services for victims of sexual violence\n",
      "1760 Youth violence: Extent of implementation of life-skills and social development programmes\n",
      "1761 Estimates of number of homicides\n",
      "1762 Estimates of rates of homicides per 100 000 population\n",
      "1763 Children aged 6-59 months who received vitamin A supplementation (%)\n",
      "1764 Warning about the dangers of tobacco\n",
      "1765 Law mandates that health warnings appear on tobacco packages\n",
      "1766 Law mandates that health warnings appear on other smoked tobacco packages\n",
      "1767 Law mandates that health warnings appear on smokeless tobacco packages\n",
      "1768 Do the health warnings on cigarette packaging include a photograph or graphic?\n",
      "1769 Do the health warnings on other smoked tobacco packaging include a photograph or graphic?\n",
      "1770 Do the health warnings on smokeless tobacco packaging include a photograph or graphic?\n",
      "1771 Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale?\n",
      "1772 Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale?\n",
      "1773 Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale?\n",
      "1774 Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale\n",
      "1775 Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale\n",
      "1776 Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale\n",
      "1777 Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry\n",
      "1778 Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry\n",
      "1779 Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry\n",
      "1780 Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health?\n",
      "1781 Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health?\n",
      "1782 Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health?\n",
      "1783 Does the law mandate specific health warnings on cigarette packaging?\n",
      "1784 Does the law mandate specific health warnings on other smoked tobacco packaging?\n",
      "1785 Does the law mandate specific health warnings on smokeless tobacco packaging?\n",
      "1786 How many health warnings are approved by the law for cigarette packaging?\n",
      "1787 How many health warnings are approved by the law for other smoked tobacco packaging?\n",
      "1788 How many health warnings are approved by the law for smokeless tobacco packaging?\n",
      "1789 Health warnings on cigarette packaging law requires or establishes fines for violations\n",
      "1790 Health warnings on other smoked tobacco packaging law requires or establishes fines for violations\n",
      "1791 Health warnings on smokeless tobacco packaging law requires or establishes fines for violations\n",
      "1792 Ban on deceitful terms on cigarette packaging\n",
      "1793 Ban on deceitful terms on other smoked tobacco packaging\n",
      "1794 Ban on deceitful terms on smokeless tobacco packaging\n",
      "1795 Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors\n",
      "1796 Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors\n",
      "1797 Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors\n",
      "1798 Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging\n",
      "1799 Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging\n",
      "1800 Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging\n",
      "1801 Cigarette packaging and labelling must not use descriptors depicting flavours\n",
      "1802 Other smoked tobacco packaging and labelling must not use descriptors depicting flavours\n",
      "1803 Smokeless tobacco packaging and labelling must not use descriptors depicting flavours\n",
      "1804 Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark\n",
      "1805 Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark\n",
      "1806 Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark\n",
      "1807 Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions\n",
      "1808 Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions\n",
      "1809 Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions\n",
      "1810 Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas\n",
      "1811 Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas\n",
      "1812 Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas\n",
      "1813 Cigarette packaging and labelling must not display expiry dates\n",
      "1814 Other smoked tobacco packaging and labelling must not display expiry dates\n",
      "1815 Smokeless tobacco packaging and labelling must not display expiry dates\n",
      "1816 The quit line number must appear on cigarette packaging or labelling\n",
      "1817 The quit line number must appear on other smoked tobacco packaging or labelling\n",
      "1818 The quit line number must appear on smokeless tobacco packaging or labelling\n",
      "1819 Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).\n",
      "1820 Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).\n",
      "1821 Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).\n",
      "1822 The sale of all smokeless tobacco products is completely banned\n",
      "1823 Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging\n",
      "1824 Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging\n",
      "1825 Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging\n",
      "1826 Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging\n",
      "1827 Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging\n",
      "1828 Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging\n",
      "1829 Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package\n",
      "1830 Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package\n",
      "1831 Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package\n",
      "1832 Does the law mandate font style, font size and colour of health warnings on cigarette packaging?\n",
      "1833 Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging?\n",
      "1834 Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging?\n",
      "1835 Are the health warnings on cigarette packaging rotating?\n",
      "1836 Are the health warnings on other smoked tobacco packaging rotating?\n",
      "1837 Are the health warnings on smokeless tobacco packaging rotating?\n",
      "1838 Are the health warnings on cigarette packaging written in the principal language(s) of the country?\n",
      "1839 Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country?\n",
      "1840 Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country?\n",
      "1841 Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps\n",
      "1842 Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps\n",
      "1843 Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps\n",
      "1844 Wasting prevalence in children aged < 5 years (%)\n",
      "1845 Life expectancy at birth (years)\n",
      "1846 Healthy life expectancy (HALE) at birth (years)\n",
      "1847 Neonatal mortality rate (per 1000 live births)\n",
      "1848 Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)\n",
      "1849 Infants exclusively breastfed for the first six months of life (%)\n",
      "1850 Healthy life expectancy (HALE) at age 60 (years)\n",
      "1851 Stillbirth rate (per 1000 total births)\n",
      "1852 Life expectancy at age 60 (years)\n",
      "1853 Preterm birth rate (per 100 live births)\n",
      "1854 Civil registration coverage of cause-of-death (%)\n",
      "1855 Ill-defined causes in cause-of-death registration (%)\n",
      "1856 Distribution of years of life lost by major cause group\n",
      "1857 Age-standardized NCD mortality rate  (per 100 000 population)\n",
      "1858 Deaths due to HIV/AIDS (per 100 000 population)\n",
      "1859 Deaths due to malaria (per 100 000 population)\n",
      "1860 Age-standardized mortality rate by cause (per 100 000 population) - Cancer\n",
      "1861 Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular\n",
      "1862 Distribution of years of life lost by broader causes (%) - Injuries\n",
      "1863 Diphtheria - number of reported cases\n",
      "1864 Japanese encephalitis - number of reported cases\n",
      "1865 Pertussis - number of reported cases\n",
      "1866 Number of new leprosy cases\n",
      "1867 Total tetanus - number of reported cases\n",
      "1868 Poliomyelitis - number of reported cases\n",
      "1869 Yellow fever - number of reported cases\n",
      "1870 Number of reported cases of tuberculosis\n",
      "1871 Mumps - number of reported cases\n",
      "1872 Congenital Rubella Syndrome - number of reported cases\n",
      "1873 Neonatal tetanus - number of reported cases\n",
      "1874 Rubella - number of reported cases\n",
      "1875 Measles - number of reported cases\n",
      "1876 Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)\n",
      "1877 Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%)\n",
      "1878 Children aged <5 years with diarrhoea receiving ORT (%)\n",
      "1879 Children aged <5 years with ARI symptoms who took antibiotic treatment (%)\n",
      "1880 Antenatal care coverage - at least one visit (%)\n",
      "1881 Antenatal care coverage - at least one visit, among girls aged 15-19 (%)\n",
      "1882 Births by caesarean section (%)\n",
      "1883 Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)\n",
      "1884 Children aged 6-59 months who received vitamin A supplementation (%)\n",
      "1885 Neonates protected at birth against neonatal tetanus (PAB) (%)\n",
      "1886 Hib (Hib3) immunization coverage among 1-year-olds (%)\n",
      "1887 Antenatal care coverage - at least four visits (%)\n",
      "1888 BCG immunization coverage among 1-year-olds (%)\n",
      "1889 Polio (Pol3) immunization coverage among 1-year-olds (%)\n",
      "1890 Population using solid fuels (%)\n",
      "1891 Radiotherapy units (per 1 000 000 population)\n",
      "1892 Median availability of selected generic medicines (%) - Private\n",
      "1893 Hospital beds (per 10 000 population)\n",
      "1894 Median consumer price ratio of selected generic medicines - Private\n",
      "1895 Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)\n",
      "1896 Anti-tobacco mass media campaigns\n",
      "1897 SDG 3.9.2 WASH deaths\n",
      "1898 Number of diarrhoea deaths from inadequate water, sanitation and hygiene\n",
      "1899 Number of diarrhoea deaths from inadequate hygiene\n",
      "1900 Number of diarrhoea deaths from inadequate sanitation\n",
      "1901 Number of diarrhoea deaths from inadequate water\n",
      "1902 Water, sanitation and hygiene attributable deaths ('000) in children under 5 years\n",
      "1903 Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene\n",
      "1904 Attributable fraction of diarrhoea to inadequate hygiene\n",
      "1905 Attributable fraction of diarrhoea to inadequate sanitation\n",
      "1906 Attributable fraction of diarrhoea to inadequate water\n",
      "1907 Water, sanitation and hygiene attributable deaths per 100'000 capita\n",
      "1908 Number of diarrhoea DALYs from inadequate water, sanitation and hygiene\n",
      "1909 Number of diarrhoea DALYs from inadequate hygiene\n",
      "1910 Number of diarrhoea DALYs from inadequate sanitation\n",
      "1911 Number of diarrhoea DALYs from inadequate water\n",
      "1912 Water, sanitation and hygiene  attributable deaths per 100'000 children under 5 years\n",
      "1913 Water, sanitation and hygiene attributable DALYs ('000)\n",
      "1914 Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years\n",
      "1915 Water, sanitation and hygiene attributable DALYs per 100'000 capita\n",
      "1916 Water, sanitation and hygiene  attributable DALYs per 100'000 children under 5 years\n",
      "1917 Population with basic handwashing facilities at home (%)\n",
      "1918 Population using at least basic sanitation services (%)\n",
      "1919 Population practising open defecation (%)\n",
      "1920 Population using safely managed sanitation services (%)\n",
      "1921 Population using at least basic drinking-water services (%)\n",
      "1922 Population using safely managed drinking-water services (%)\n",
      "1923 General availability of Angiotensin II receptor blockers (ARBs) in the public health sector\n",
      "1924 Existence of evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseases\n",
      "1925 Existence of a national target on NCD mortality\n",
      "1926 Legislation and Financing\n",
      "1927 Early initiation of breastfeeding (in the two years preceding the survey) (%)\n",
      "1928 Cheapest brand of cigarettes - price in PPP$\n",
      "1929 Sources of assistive products (%)\n",
      "1930 Number of indigenous P. falciparum malaria cases\n",
      "1931 Cytisine - legally sold\n",
      "1932 Existence of policy promoting physical activity: workplace initiatives\n",
      "1933 Households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)\n",
      "1934 Radiation Emergencies\n",
      "1935 Population with primary reliance on fuels and technologies)for cooking, by fuel type (in millions)\n",
      "1936 Prevalence of current cigarette smoking among adolescents (%)\n",
      "1937 Existence of a national target on essential medicines and technologies\n",
      "1938 Number of imported malaria cases\n",
      "1939 Reported use of earmarked tobacco taxes\n",
      "1940 Zoonotic Events and the Human-animal Interface\n",
      "1941 Human Resources (SPAR)\n",
      "1942 Population with primary reliance on polluting fuels and technologies for cooking (in millions)\n",
      "1943 Surveillance (SPAR)\n",
      "1944 Population with access to an insecticide-treated bed net (ITN) for malaria protection (%), modelled\n",
      "1945 Prevalence of current smokeless tobacco use among adults (%)\n",
      "1946 Name of latest youth prevalence survey (nonsmoked)\n",
      "1947 Reference level for dwellings (Bq/m3)\n",
      "1948 Care-seeking by type of patient and source of care (%)\n",
      "1949 Compliance with ban on promotional discounts (score)\n",
      "1950 Has conducted a recent, national adult risk factor survey covering tobacco use\n",
      "1951 Representation of latest adult prevalence survey (nonsmoked)\n",
      "1952 Year of latest youth prevalence survey (nonsmoked)\n",
      "1953 Compliance with ban on appearance of tobacco products in TV and/or films (score)\n",
      "1954 Total population pushed  further below the $3.20 a day poverty line by household health expenditures (millions)\n",
      "1955 Existence of national guidelines for physical activity for older adults\n",
      "1956 Compliance with smoke-free health-care facilities law (score)\n",
      "1957 Existence of national reference level for workplaces\n",
      "1958 Existence of a national target on alcohol\n",
      "1959 Has conducted a recent, national adult risk factor survey covering physical inactivity\n",
      "1960 Existence of policy promoting physical activity: walking and cycling\n",
      "1961 Estimated number of malaria deaths\n",
      "1962 Population pushed further below the $3.20 a day poverty line by household health expenditures (%)\n",
      "1963 Most sold brand of cigarettes - price in PPP$\n",
      "1964 Compliance with smoke-free government facilities law (score)\n",
      "1965 Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark\n",
      "1966 Mortality rate among children ages 5 to 9 years (per 1000 children aged 5)\n",
      "1967 Estimated malaria incidence (per 1000 population at risk)\n",
      "1968 Risk Communication (SPAR)\n",
      "1969 Ban on tobacco vending machines\n",
      "1970 Subnational bans on tobacco advertising, promotion and sponsorship authority exists\n",
      "1971 Workforce availability for assistive technology\n",
      "1972 Proportion of ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months\n",
      "1973 Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis\n",
      "1974 General availability of bone marrow transplantation in the public health system\n",
      "1975 Reference level for buildings with high public occupancy (Bq/m3)\n",
      "1976 Has conducted a recent, national adult risk factor survey covering raised total cholesterol\n",
      "1977 Existence of a national target on drug therapy and counselling\n",
      "1978 Points of Entry (SPAR)\n",
      "1979 Existence of population-based cancer registry\n",
      "1980 Mean hemoglobin level of children aged 6-59 months\n",
      "1981 Age range of latest adult prevalence survey (nonsmoked)\n",
      "1982 Reporting countries\n",
      "1983 Cheapest brand of cigarettes - price in currency reported\n",
      "1984 Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, age-standardized\n",
      "1985 Prevalence of daily smokeless tobacco use among adolescents (%)\n",
      "1986 Availability of education/training for assistive technology\n",
      "1987 Overall compliance with bans on promotion and sponsorship (score)\n",
      "1988 Mean hemoglobin level of pregnant women (aged 15-49 years)\n",
      "1989 Existence of financial mechanisms for assistive technology\n",
      "1990 Existence of any subnational radon activity\n",
      "1991 Contraceptive prevalence - use of modern methods (%)\n",
      "1992 Mean HDL cholesterol, age-standardized\n",
      "1993 Overall compliance with bans on direct advertising (score)\n",
      "1994 Representativeness of most recent survey of adults\n",
      "1995 IHR Coordination and National IHR Focal Point Functions\n",
      "1996 Number of malaria suspects examined by microscopy\n",
      "1997 Estimated number of malaria cases\n",
      "1998 Compliance with smoke-free indoor offices law (score)\n",
      "1999 Chemical Events\n",
      "2000 Prevalence of current e-cigarette use among adults (%)\n",
      "2001 Population pushed further  below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)\n",
      "2002 Laboratory (SPAR)\n",
      "2003 Number of suspected malaria cases\n",
      "2004 Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime\n",
      "2005 Prevalence of hypertension among adults aged 30-79 years, age-standardized\n",
      "2006 National Health Emergency Framework\n",
      "2007 Prevalence of hypertension among adults aged 30-79 years, crude\n",
      "2008 Cytisine - place available\n",
      "2009 BCG immunization coverage among one-year-olds (%)\n",
      "2010 Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months\n",
      "2011 General availability of Fixed dose combination avail (telmisartan + hydrochlorothiazide) in the public health sector\n",
      "2012 Status of indigenous malaria cases\n",
      "2013 Existence of tax on foods high in fat, sugars or salt\n",
      "2014 Publication year of the policy or plan (latest revision)\n",
      "2015 Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population\n",
      "2016 Existence of operational policy/strategy/action plan for eye health\n",
      "2017 Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, age-standardized\n",
      "2018 Number of indigenous P. vivax malaria cases\n",
      "2019 Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA), median (%)\n",
      "2020 Existence of national guidelines for physical activity for children and adolescents aged 5-19\n",
      "2021 Proportion of vaccination cards seen (%)\n",
      "2022 Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP\n",
      "2023 Existence of evidence-based national guidelines/protocols/standards for the management of cancer\n",
      "2024 Number of indigenous malaria cases\n",
      "2025 Inclusion of radon education for building professionals\n",
      "2026 Existence of policy promoting physical activity: childcare settings\n",
      "2027 Existence of initiatives/collaborations on assistive technology\n",
      "2028 Number of confirmed malaria cases\n",
      "2029 Compliance with ban on indentifying non-tobacco products with tobacco brand names (score)\n",
      "2030 Prevalence of anaemia in non-pregnant women (aged 15-49) (%)\n",
      "2031 Satisfaction with assistive products for different environments and activities (%)\n",
      "2032 Compliance with ban on advertising at point of sale (score)\n",
      "2033 Number of malaria suspects examined by rapid diagnostic test (RDT)\n",
      "2034 General availability of blood pressure measurement at the primary health care level\n",
      "2035 Has conducted a recent, national adult risk factor survey covering raised blood pressure/hypertension\n",
      "2036 Underweight prevalence in children aged < 5 years (%) (Health inequality monitor)\n",
      "2037 Care-seeking by type of patient and source of care (%) (see CARE_SOURCE)\n",
      "2038 Status of endemicity of buruli ulcder\n",
      "2039 Compliance with smoke-free restaurants law (score)\n",
      "2040 Estimate of current tobacco smoking prevalence (%)\n",
      "2041 Mean total cholesterol,  crude\n",
      "2042 Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)\n",
      "2043 Authorization/accreditation required for official radon measurement providers\n",
      "2044 Prevalence of daily smokeless tobacco use among adults (%)\n",
      "2045 Ban on Corporate Social Responsibility activities (CSR)\n",
      "2046 One-year-old children who have not received any doses of the DTP vaccine (%)\n",
      "2047 Existence of evidence-based national guidelines/protocols/standards for the management of alcohol use disorders\n",
      "2048 Satisfaction with assistive products and related services (%)\n",
      "2049 General availability of diabetic retinopathy screening in the public health system\n",
      "2050 Barriers to accessing assistive products (%)\n",
      "2051 Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, crude\n",
      "2052 Compliance with ban on billboard and outdoor advertising (score)\n",
      "2053 Existence of policy promoting physical activity: public open spaces\n",
      "2054 Prevalence of anaemia in women of reproductive age (aged 15-49) (%)\n",
      "2055 Reported number of tests performed where results were received by a person (testing volume)\n",
      "2056 Existence of evidence-based national guidelines/protocols/standards for the management of cardiovascular diseases\n",
      "2057 Existence of a national target on physical inactivity\n",
      "2058 Has conducted a recent, national adult risk factor survey covering overweight and obesity\n",
      "2059 Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, age-standardized\n",
      "2060 Compliance with ban on advertising in local magazines and newspapers (score)\n",
      "2061 Age range of most recent adolescent survey\n",
      "2062 Implementation of a recent mass participation event\n",
      "2063 Mean HDL cholesterol, crude\n",
      "2064 Compliance with smoke-free education facilities except universities law (score)\n",
      "2065 Title of most recent survey of adults\n",
      "2066 Existence of national radon map\n",
      "2067 Total population pushed   further  below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (millions)\n",
      "2068 Travel distance to obtain assistive products (%)\n",
      "2069 Institutional Births (birth taken place in a facility) (%)\n",
      "2070 Population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)\n",
      "2071 Existence of evidence-based national guidelines/protocols/standards for the management of tobacco dependence\n",
      "2072 Women of reproductive age (15−49 years) who are married or in-union who have their need for family planning satisfied with modern methods (%), UNPD\n",
      "2073 Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)\n",
      "2074 Estimate of current cigarette smoking prevalence (%) (age-standardized rate)\n",
      "2075 Proportion of bloodstream infection due Escherichia coli resistant to 3rd-generation cephalosporin, median (%)\n",
      "2076 Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%)\n",
      "2077 Compliance with ban on free distribution in mail or through other means (score)\n",
      "2078 Prevalence of daily tobacco smoking among adolescents (%)\n",
      "2079 Existence of a national target on obesity\n",
      "2080 Low birth weight (in thousands)\n",
      "2081 Low birth weight, prevalence (%)\n",
      "2082 Prevalence of need of assistive products (%)\n",
      "2083 Existence of national policy instruments for occupational health and safety for health workers\n",
      "2084 Total population pushed further below the $1.90 a day poverty line by household health expenditures (%)\n",
      "2085 Total population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (millions)\n",
      "2086 Number of surveillance sites reporting to GLASS: In- and outpatient facilities\n",
      "2087 General availability of cancer surgery in the public sector\n",
      "2088 Total population pushed  further  below the $3.20 a day poverty line by household health expenditures (%)\n",
      "2089 Indicator 16.2.1: Proportion of children aged 1-17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month\n",
      "2090 Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP\n",
      "2091 Process evaluation was employed to assess implementation of the campaign\n",
      "2092 General availability of cancer centres or cancer departments at tertiary level in the public sector\n",
      "2093 Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP\n",
      "2094 Existence of national guidelines for physical activity for children under 5\n",
      "2095 Number of malaria cases treated with artemisinin-based combination therapies (ACTs)\n",
      "2096 Number of children aged 6–59 months with anaemia (thousands)\n",
      "2097 Existence of policy promoting physical activity: community-based and sports initiatives\n",
      "2098 Number of reported cases of poliomyelitis by wild poliovirus (WPV)\n",
      "2099 Prevalence of current tobacco smoking among adults (%)\n",
      "2100 Number of malaria positive cases by microscopy\n",
      "2101 Prevalence of current smokeless tobacco use among adolescents (%)\n",
      "2102 Compliance with smoke-free pubs and bars law (score)\n",
      "2103 Prevalence of current cigarette smoking among adults (%)\n",
      "2104 Girls aged 15 years old that received the recommended doses of HPV vaccine (%)\n",
      "2105 Prevalence of daily cigarette smoking among adolescents (%)\n",
      "2106 Existence of responsible ministry/authority on assistive technology\n",
      "2107 Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP\n",
      "2108 Existence of operational policy/strategy/action plan for hearing health\n",
      "2109 Representation of latest youth prevalence survey (nonsmoked)\n",
      "2110 Number of pregnant women (aged 15-49 years) with anaemia (thousands)\n",
      "2111 Amount of water- and sanitation-related official development assistance that is part of a government-coordinated spending plan (current US$ millions)\n",
      "2112 Year of most recent adolescent survey\n",
      "2113 General availability of pathology services (laboratories) in the public sector\n",
      "2114 Health Service Provision\n",
      "2115 Prevalence of current tobacco use among adults (%)\n",
      "2116 Existence of legislation on access to assistive technology\n",
      "2117 Proportion of isolates with resistance to azithromycin reported to WHO-GASP\n",
      "2118 Prevalence of daily e-cigarette use among adolescents (%)\n",
      "2119 Total number of surveillance sites reporting to GLASS\n",
      "2120 Ban on tobacco companies/the tobacco industry publicizing their CSR activities\n",
      "2121 Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place\n",
      "2122 Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line (60% of median daily per capita consumption or income) (%)\n",
      "2123 Prevalence of anaemia in children aged 6–59 months (%)\n",
      "2124 Existence of evidence-based national guidelines/protocols/standards for the management of physical inactivity\n",
      "2125 Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, crude\n",
      "2126 Existence of national policies on trans-fatty acid elimination\n",
      "2127 Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry\n",
      "2128 Cheapest brand of cigarettes - price in US$ at official exchange rates\n",
      "2129 Mean Non-HDL cholesterol, crude\n",
      "2130 Coverage of people in need of assistive technology by legislation\n",
      "2131 Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score)\n",
      "2132 Compliance with ban on advertising on national television and radio (score)\n",
      "2133 Cytisine - cost covered\n",
      "2134 ICD-11 implementation progress level\n",
      "2135 Reference level for workplaces (Bq/m3)\n",
      "2136 Compliance with smoke-free public transport law (score)\n",
      "2137 Nursing personnel (%)\n",
      "2138 Mean total cholesterol,  age-standardized\n",
      "2139 Number of deaths among children ages 10 to 14 years\n",
      "2140 Has conducted a recent, national adult risk factor survey covering harmful alcohol use\n",
      "2141 Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place\n",
      "2142 Year the law was enacted (latest revision)\n",
      "2143 Number of malaria positive cases by rapid diagnostic test (RDT)\n",
      "2144 Most sold brand of cigarettes - price in US$ at official exchange rates\n",
      "2145 Total population pushed  further below the $1.90 a day poverty line by household health expenditures (millions)\n",
      "2146 Proportion of population with primary reliance on polluting fuels and technologies for cooking (%)\n",
      "2147 Implementation of a nutrition public awareness program\n",
      "2148 Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes\n",
      "2149 Existence of a national target on tobacco\n",
      "2150 Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities) by out-of-pocket payments (%)\n",
      "2151 Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, crude\n",
      "2152 Compliance with ban on appearance of tobacco brands in TV and/or films (score)\n",
      "2153 General availability of Fixed dose combination avail (lisinopril + amlodipine) in the public health sector\n",
      "2154 Number of malaria cases treated with any first  line tx courses (including artemisinin-based combination therapies (ACTs))\n",
      "2155 Mean hemoglobin level of women of reproductive age (aged 15-49 years)\n",
      "2156 Has conducted a recent, national adult risk factor survey covering raised blood glucose/diabetes\n",
      "2157 Existence of policy promoting physical activity: active ageing\n",
      "2158 Number of deaths among children ages 5 to 9 years\n",
      "2159 Name of latest adult prevalence survey (nonsmoked)\n",
      "2160 Existence of tax incentives to promote physical activity\n",
      "2161 SDG 6.3.1 Proportion of safely treated domestic wastewater flows (%)\n",
      "2162 Availability of government/registered services for assistive technology\n",
      "2163 Number of confirmed yaws cases reported\n",
      "2164 Full immunization coverage among one-year-olds (%)\n",
      "2165 Population pushed further below the $1.90 a day poverty line by household health expenditures (%)\n",
      "2166 Population with primary reliance on clean fuels and technologies for cooking (in millions)\n",
      "2167 General availability of radiotherapy in the public sector\n",
      "2168 General availability of dilated fundus examination at the primary health care level\n",
      "2169 Medical doctors (%)\n",
      "2170 Estimated malaria mortality rate (per 100 000 population)\n",
      "2171 Prevalence of current tobacco use among adolescents (%)\n",
      "2172 Affordability – category of change 2010-2020 (Yes (less affordable), No (more affordable), No change).\n",
      "2173 Age range of latest youth prevalence survey (nonsmoked)\n",
      "2174 Existence of a national target on salt\n",
      "2175 Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%)\n",
      "2176 Severe wasting prevalence in children aged < 5 years (%)\n",
      "2177 Existence of a national target on blood pressure / hypertension\n",
      "2178 Mortality rate among children ages 10 to 14 years (per 1000 children aged 10)\n",
      "2179 Availability of public funding for assistive technology\n",
      "2180 Funding for assistive products (%)\n",
      "2181 Year of most recent survey of adults\n",
      "2182 Number of isolates tested for ciprofloxacin\n",
      "2183 Prevalence of current tobacco smoking among adolescents (%)\n",
      "2184 General availability of Fixed dose combination avail (telmisartan + amlodipine) in the public health sector\n",
      "2185 Proportion of population with primary reliance on clean fuels and technologies for cooking (%)\n",
      "2186 General availability of Fixed dose combination avail (lisinopril + hydrochlorothiazide) in the public health sector\n",
      "2187 Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products\n",
      "2188 Pregnant women attending antenatal care  at least once and receiving at least 3 doses of Intermittent Preventive Treatment of Malaria for Pregnant Women (IPTp3) (%)\n",
      "2189 Measles immunization coverage among one-year-olds (%)\n",
      "2190 Reported number of tests performed where results were received by a person (testing volume), reporting period\n",
      "2191 Number of presumed malaria cases\n",
      "2192 Total population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)\n",
      "2193 Existence of operational policy/strategy/action plan to reduce overweight/obesity\n",
      "2194 Title of most recent adolescent survey\n",
      "2195 Existence of evidence-based national guidelines/protocols/standards for the management of overweight/obesity\n",
      "2196 General availability of combination budesonide formoterol inhaler in the public health sector\n",
      "2197 Mean Non-HDL cholesterol, age-standardized\n",
      "2198 Number of suspected yaws cases reported\n",
      "2199 Existence of a national target on diabetes\n",
      "2200 Has conducted a recent, national adult risk factor survey covering unhealthy diet\n",
      "2201 Demand for family planning satisfied - use of modern methods (%)\n",
      "2202 Number of isolates tested for azithromycin\n",
      "2203 Prevalence of daily cigarette smoking among adults (%)\n",
      "2204 Has conducted a recent, national adult risk factor survey covering salt/sodium intake\n",
      "2205 Existence of regulations/standards/guidelines/protocols on assistive technology\n",
      "2206 Estimate of current tobacco use prevalence (%) (age-standardized rate)\n",
      "2207 Number of non-pregnant women (aged 15-49 years) with anaemia (thousands)\n",
      "2208 Total population pushed  further  below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)\n",
      "2209 Existence of national guidelines for physical activity\n",
      "2210 Ban on advertising at point of sale\n",
      "2211 Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%)\n",
      "2212 Prevalence of current e-cigarette use among adolescents (%)\n",
      "2213 Prevalence of daily tobacco smoking among adults (%)\n",
      "2214 Existence of evidence-based national guidelines/protocols/standards for the management of diabetes\n",
      "2215 Number of people protected from malaria by indoor residual spraying (IRS)\n",
      "2216 Ban on sale of duty-free or excise-free cigarettes\n",
      "2217 Representativeness of most recent adolescent survey\n",
      "2218 Prevalence of anaemia in pregnant women (aged 15-49) (%)\n",
      "2219 A minimum price policy is implemented\n",
      "2220 Average of 13 International Health Regulations core capacity scores, SPAR version, 1st edition\n",
      "2221 Compliance with smoke-free universities law (score)\n",
      "2222 Polio immunization coverage among one-year-olds (%)\n",
      "2223 Mean hemoglobin level of non-pregnant women (aged 15-49 years)\n",
      "2224 Law requires fines for violations of advertising bans\n",
      "2225 Proportion of population with primary reliance on fuels and technologies for cooking, by fuel type (%)\n",
      "2226 Compliance with ban on use of brand name of non-tobacco product for tobacco product (score)\n",
      "2227 General availability of foot vibration perception by tuning fork at the primary health care level\n",
      "2228 Law requires fines for violations of promotion and sponsorship bans\n",
      "2229 Food Safety (SPAR)\n",
      "2230 DTP3 immunization coverage among one-year-olds (%)\n",
      "2231 Existence of price subsidies for healthy foods\n",
      "2232 New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population\n",
      "2233 Number of isolates tested for extended-spectrum cephalosporins\n",
      "2234 Number of isolates tested for ceftriaxone\n",
      "2235 Prevalence of use of assistive products (%)\n",
      "2236 Prevalence of daily tobacco use among adults (%)\n",
      "2237 Age range of most recent survey of adults\n",
      "2238 Total number of  malaria cases (presumed + confirmed cases)\n",
      "2239 Persistence to last grade of primary (% of cohort)\n",
      "2240 Existence of national radon action plan - Years covered\n",
      "2241 Estimate of current tobacco smoking prevalence (%) (age-standardized rate)\n",
      "2242 General availability of alteplase for acute stroke management in the public health system\n",
      "2243 Year of latest adult prevalence survey (nonsmoked)\n",
      "2244 Existence of national guidelines for physical activity for adults\n",
      "2245 Prevalence of daily e-cigarette use among adults (%)\n",
      "2246 Overall compliance with regulations on smoke-free environments (score)\n",
      "2247 Number of isolates tested for cefixime\n",
      "2248 Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N)\n",
      "2249 General availability of urine strips for glucose and ketone measurement at the primary health care level\n"
     ]
    }
   ],
   "source": [
    "index = 0 \n",
    "\n",
    "who_data = requests.get(who_url).json()\n",
    "for indicator in who_data['value']:\n",
    "    print(index, indicator['IndicatorName'])\n",
    "    index += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "66b44593",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'IndicatorCode': 'GOE_Q058',\n",
       " 'IndicatorName': 'Infrastructure',\n",
       " 'Language': 'EN'}"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "who_data['value'][450]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "5b3ffa6a",
   "metadata": {},
   "outputs": [],
   "source": [
    "infra_url = 'https://ghoapi.azureedge.net/api/GOE_Q058'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "57bffc5b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'@odata.context': 'https://ghoapi.azureedge.net/api/$metadata#GOE_Q058',\n",
       " 'value': [{'Id': 18125096,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SOM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.197+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125108,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'KIR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.447+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125113,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MDA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.55+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125117,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'VNM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.64+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125125,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'KEN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.807+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125133,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'UGA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.987+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125136,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'AZE',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:39.05+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125150,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SWE',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:39.353+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125155,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BTN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:39.457+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125158,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'HRV',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:39.533+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125160,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GEO',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:39.573+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125180,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'LTU',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:40.027+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125181,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'LUX',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:40.05+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125192,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BIH',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:40.263+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125194,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CUB',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:40.3+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125205,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ESP',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:40.52+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123162,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CIV',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:51.62+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123182,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GTM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:52.083+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123183,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'JOR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:52.107+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123187,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'POL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:52.2+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123212,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CAN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:52.927+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123214,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'DNK',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:53.01+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123237,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MRT',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:53.51+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123238,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'PRY',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:53.53+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123240,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SVN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:53.57+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123251,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ITA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:53.8+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123256,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'RUS',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:53.897+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123270,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MLT',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:54.2+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123283,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GNB',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:54.5+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123288,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'PHL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:54.653+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123436,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'AUT',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:58.257+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123437,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BHR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:58.31+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123440,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GNQ',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:58.417+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123476,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'LAO',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:59.333+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123481,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'QAT',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:59.457+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123484,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'URY',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:59.54+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123488,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'COL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:35:59.637+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123508,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GRC',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:00.117+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123517,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SSD',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:00.31+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123523,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BFA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:00.537+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123538,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ARM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:00.977+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123554,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'AFG',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:01.363+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123562,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'LBN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:01.57+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123714,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'PAN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:05.21+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123726,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ISL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:05.46+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123732,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'PER',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:05.59+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123737,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BGR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:05.723+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123751,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'TLS',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:06.05+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123764,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MDG',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:06.333+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123766,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MNG',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:06.38+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123769,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ZAF',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:06.44+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123783,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MYS',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:06.747+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123791,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'DZA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:06.95+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123795,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'PRK',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:07.067+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123800,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'LVA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:07.193+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123807,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ZMB',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:07.377+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123811,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CHN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:07.49+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123812,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'COM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:07.52+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123841,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'UKR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:08.21+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123843,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'UZB',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:08.26+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123986,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CAF',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:11.81+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123989,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'IRN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:11.89+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123992,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MWI',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:11.953+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123993,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'NLD',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:11.973+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18123994,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'NER',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:12+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124002,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BDI',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:12.173+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124007,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ISR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:12.293+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124025,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'LSO',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:12.76+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124029,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ROU',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:12.853+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124032,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ZWE',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:12.943+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124036,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CRI',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.063+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124039,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'FIN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.13+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124044,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MLI',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.24+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124045,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'PAK',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.247+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124053,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'AUS',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.41+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124056,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SLV',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.47+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124062,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'NZL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.6+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124065,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'RWA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.67+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124066,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SYR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.693+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124076,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'KAZ',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:13.953+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124085,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'USA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:14.18+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124105,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ARG',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:14.62+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124106,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'KHM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:14.64+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124111,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'IRL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:14.75+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124119,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'TUN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:14.96+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124275,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'TJK',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:18.34+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124299,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'HND',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:18.843+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124311,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BEL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:19.09+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124315,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'EST',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:19.197+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124328,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'TUR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:19.49+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124331,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BGD',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:19.557+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124333,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CHL',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:19.603+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124351,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CZE',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.05+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124353,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'HUN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.1+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124362,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'TKM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.353+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124365,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BLR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.417+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124369,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ETH',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.517+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124373,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MDV',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.61+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124374,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MNE',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.633+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124377,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SGP',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:20.697+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124551,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CHE',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:25.107+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124568,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'TTO',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:25.557+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124569,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GBR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:25.58+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124578,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'JAM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:25.803+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124609,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CYP',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:26.597+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124616,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'NOR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:26.78+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124618,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SEN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:26.833+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124622,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'ALB',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:26.933+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124646,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GMB',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:27.463+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124664,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'JPN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:27.903+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124665,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'KGZ',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:27.93+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124816,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'DOM',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:31.53+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124823,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SMR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'No response',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:31.697+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124875,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SYC',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:33.06+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124886,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'IRQ',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Very important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:33.29+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124889,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MAR',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:33.367+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124911,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'PRT',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:33.853+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124927,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'OMN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Slightly important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:34.197+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124930,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'SRB',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Not a barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:34.26+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18124935,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'CPV',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Moderately important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:34.38+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125085,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'BEN',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:37.957+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125089,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'GHA',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.047+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'},\n",
       "  {'Id': 18125093,\n",
       "   'IndicatorCode': 'GOE_Q058',\n",
       "   'SpatialDimType': 'COUNTRY',\n",
       "   'SpatialDim': 'MEX',\n",
       "   'TimeDimType': 'YEAR',\n",
       "   'TimeDim': 2015,\n",
       "   'Dim1Type': 'GOEQUESTION',\n",
       "   'Dim1': 'GOEQUESTION008',\n",
       "   'Dim2Type': None,\n",
       "   'Dim2': None,\n",
       "   'Dim3Type': None,\n",
       "   'Dim3': None,\n",
       "   'DataSourceDimType': None,\n",
       "   'DataSourceDim': None,\n",
       "   'Value': 'Extremely important barrier',\n",
       "   'NumericValue': None,\n",
       "   'Low': None,\n",
       "   'High': None,\n",
       "   'Comments': None,\n",
       "   'Date': '2018-03-28T13:36:38.127+02:00',\n",
       "   'TimeDimensionValue': '2015',\n",
       "   'TimeDimensionBegin': '2015-01-01T00:00:00+01:00',\n",
       "   'TimeDimensionEnd': '2015-12-31T00:00:00+01:00'}]}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "infra_data = requests.get(infra_url).json()\n",
    "infra_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8bb4bc5e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
